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A B S T R A C T
Background
At birth, infants’ lungs are fluid-filled. For newborns to have a successful transition, this fluid must be replaced by air to enable effective
breathing. Some infants are judged to have inadequate breathing at birth and are resuscitated with positive pressure ventilation (PPV).
Giving prolonged (sustained) inflations at the start of PPV may help clear lung fluid and establish gas volume within the lungs.
Objectives
To assess the efficacy of an initial sustained (> 1 second duration) lung inflation versus standard inflations (≤ 1 second) in newly born
infants receiving resuscitation with intermittent PPV.
Search methods
We used the standard search strategy of the Cochrane Neonatal Review Group to search the Cochrane Central Register of Controlled
Trials (CENTRAL; 2017, Issue 1), MEDLINE via PubMed (1966 to 17 February 2017), Embase (1980 to 17 February 2017), and
the Cumulative Index to Nursing and Allied Health Literature (CINAHL) (1982 to 17 February 2017). We also searched clinical
trials databases, conference proceedings, and the reference lists of retrieved articles to identify randomised controlled trials and quasi-
randomised trials.
Selection criteria
Randomised controlled trials (RCTs) and quasi-RCTs comparing initial sustained lung inflation (SLI) versus standard inflations given
to infants receiving resuscitation with PPV at birth.
1Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Data collection and analysis
We assessed the methodological quality of included trials using Cochrane Effective Practice and Organisation of Care Group (EPOC)
criteria (assessing randomisation, blinding, loss to follow-up, and handling of outcome data). We evaluated treatment effects using a
fixed-effect model with risk ratio (RR) for categorical data and mean, standard deviation (SD), and weighted mean difference (WMD)
for continuous data. We assessed the quality of evidence using the Grading of Recommendations Assessment, Development, and
Evaluation (GRADE) approach.
Main results
Eight trials enrolling 941 infants met our inclusion criteria. Investigators in seven trials (932 infants) administered sustained inflation
with no chest compressions. Use of sustained inflation had no impact on the primary outcomes of this review - mortality in the delivery
room (typical RR 2.66, 95% confidence interval (CI) 0.11 to 63.40; participants = 479; studies = 5; I² not applicable) and mortality
during hospitalisation (typical RR 1.01, 95% CI 0.67 to 1.51; participants = 932; studies = 7; I² = 19%); the quality of the evidence
was low for death in the delivery room (limitations in study design and imprecision of estimates) and was moderate for death before
discharge (limitations in study design of most included trials). Amongst secondary outcomes, duration of mechanical ventilation was
shorter in the SLI group (mean difference (MD) -5.37 days, 95% CI -6.31 to -4.43; participants = 524; studies = 5; I² = 95%; low-
quality evidence). Heterogeneity, statistical significance, and magnitude of effects of this outcome are largely influenced by a single
study: When this study was removed from the analysis, the effect was largely reduced (MD -1.71 days, 95% CI -3.04 to -0.39, I² = 0%).
Results revealed no differences in any of the other secondary outcomes (e.g. rate of endotracheal intubation outside the delivery room
by 72 hours of age (typical RR 0.93, 95% CI 0.79 to 1.09; participants = 811; studies = 5; I² = 0%); need for surfactant administration
during hospital admission (typical RR 0.97, 95% CI 0.86 to 1.10; participants = 932; studies = 7; I² = 0%); rate of chronic lung
disease (typical RR 0.95, 95% CI 0.74 to 1.22; participants = 683; studies = 5; I² = 47%); pneumothorax (typical RR 1.44, 95% CI
0.76 to 2.72; studies = 6, 851 infants; I² = 26%); or rate of patent ductus arteriosus requiring pharmacological treatment (typical RR
1.08, 95% CI 0.90 to 1.30; studies = 6, 745 infants; I² = 36%). The quality of evidence for these secondary outcomes was moderate
(limitations in study design of most included trials - GRADE) except for pneumothorax (low quality: limitations in study design and
imprecision of estimates - GRADE).
Authors’ conclusions
Sustained inflation was not better than intermittent ventilation for reducing mortality in the delivery room and during hospitalisation.
The number of events across trials was limited, so differences cannot be excluded. When considering secondary outcomes, such as need
for intubation, need for or duration of respiratory support, or bronchopulmonary dysplasia, we found no evidence of relevant benefit
for sustained inflation over intermittent ventilation. The duration of mechanical ventilation was shortened in the SLI group. This result
should be interpreted cautiously, as it can be influenced by study characteristics other than the intervention. Future RCTs should aim
to enrol infants who are at higher risk of morbidity and mortality, should stratify participants by gestational age, and should provide
more detailed monitoring of the procedure, including measurements of lung volume and presence of apnoea before or during the SLI.
P L A I N L A N G U A G E S U M M A R Y
Prolonged lung inflation for neonatal resuscitation
Review question
Does the use of prolonged (or sustained, > 1 second duration) lung inflation rather than standard inflations (≤ 1 second) improve
survival and other important outcomes among newly born babies receiving resuscitation at birth?
Background
At birth, the lungs are filled with fluid, which must be replaced by air for babies to breathe properly. Some babies have difficulty
establishing effective breathing at birth, and 1 in every 20 to 30 babies receives help to do so. A variety of devices are used to help
babies begin normal breathing. Some of these devices allow caregivers to give long (or sustained) inflations. These sustained inflations
may help inflate the lungs and may keep the lungs inflated better than if they are not used.
Study characteristics
We collected and analysed all relevant studies to answer the review question and found eight studies enrolling 941 infants. In all studies,
babies were born before the due date (from 23 to 36 weeks of gestational age). The sustained inflation lasted between 15 and 20 seconds
2Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
at pressure between 20 and 30 cmH2O. Most studies provided one or more additional sustained inflations in cases of poor clinical
response, for example, persistent low heart rate.We analysed one study (which included only nine babies) separately because researchers
combined use of sustained or standard inflations with chest compressions.
Key results
The included studies showed no important differences among babies who received sustained versus standard inflations in terms of
mortality, need for intubation during the first three days of life, or chronic lung disease. Babies receiving sustained inflation at birth
may spend fewer days on mechanical ventilation. Several ongoing studies might help us to clarify whether differences between the two
techniques may occur, as now we cannot exclude that small to moderate differences exist.
Quality of evidence
The quality of evidence is low to moderate because overall only a small number of studies have looked at this intervention; few babies
were included in these studies; and some studies could have been better designed.
How up-to-date is this review?
We searched for studies that had been published up to February 2017.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Use of initial sustained inflation compared with standard inflations in newborns receiving resuscitation with no chest compressions during resuscitation
Patient or population: preterm infants resuscitated using PPV at birth
Settings: delivery room in Europe (Austria, Germany, Italy), Canada, Egypt, Thailand
Intervention: sustained inf lat ion with no chest compressions
Comparison: standard inf lat ions with no chest compressions
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No. of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Standard inflations in
newborns receiving re-
suscitation with no
chest compressions
Use of initial sustained
inflation
Death - death in the de-
livery room
Study population RR 2.66
(0.11 to 63.4)
479
(5 studies)
⊕⊕©©
lowa,b
0 per 1000 0 per 1000
(0 to 0)
Death - death before
discharge
Study population RR 1.01
(0.67 to 1.51)
932
(7 studies)
⊕⊕⊕©
moderatea
82 per 1000 83 per 1000
(55 to 124)
Need for mechanical
ventilation
Study population RR 0.87
(0.74 to 1.03)
484
(3 studies)
⊕⊕⊕©
moderatea
487 per 1000 424 per 1000
(360 to 502)
Chronic lung disease -
BPD any grade
Study population RR 0.9
(0.69 to 1.19)
220
(2 studies)
⊕⊕⊕©
moderatea
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483 per 1000 435 per 1000
(333 to 575)
Chronic lung disease
- moderate to severe
BPD
Study population RR 0.95
(0.74 to 1.22)
683
(5 studies)
⊕⊕⊕©
moderatea
257 per 1000 244 per 1000
(190 to 314)
Pneumothorax - any
time
Study population RR 1.44
(0.76 to 2.72)
851
(6 studies)
⊕⊕©©
lowa,c
33 per 1000 48 per 1000
(25 to 90)
Cranial ultrasound ab-
normalities - intraven-
tricular haemorrhage
grade 3 to 4
Study population RR 0.89
(0.58 to 1.37)
635
(5 studies)
⊕⊕⊕©
moderatea
120 per 1000 107 per 1000
(70 to 164)
* The basis for the assumed risk (e.g. median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is based on
the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI)
CI: conf idence interval; RR: risk rat io
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate
Very low quality: We are very uncertain about the est imate
Assumed risk is the risk of the control arm.
aLim itat ions in study design: all studies at high or unclear risk of bias in at least one domain
bImprecision: few events
cImprecision: wide conf idence intervals
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B A C K G R O U N D
Description of the condition
At birth, infants’ lungs are filled with fluid, which must be cleared
for effective respiration to occur. Most newly born infants achieve
this spontaneously and may use considerable negative pressure (up
to -50 cmH2O) for initial inspirations (Karlberg 1962; Milner
1977). However, it is estimated that 3% to 5% of newly born
infants receive some help to breathe at delivery (Saugstad 1998).
Adequate ventilation is the key to successful neonatal resuscita-
tion and stabilisation (Wyckoff 2015). Positive pressure ventila-
tion (PPV) is recommended for infants who have absent or inad-
equate respiratory efforts, bradycardia, or both, at birth (Wyckoff
2015). Use ofmanual ventilation devices - self-inflating bags, flow-
inflating (or anaesthetic) bags, and T-piece devices - with a face
mask or endotracheal tube (ETT) is advised. Although it is not
included in the International Liaison Committee on Resuscitation
(ILCOR) guidelines, respiratory support of infants in the delivery
room with a mechanical ventilator and a nasopharyngeal tube has
been described (Lindner 1999).
Description of the intervention
Devices recommended for PPV in the delivery room differ in
terms of physical characteristics and ability to deliver sustained
lung inflation (SLI). The most commonly used self-inflating bag
(O’Donnell 2004a; O’Donnell 2004b) may be of insufficient size
to support sustained inflation (> 1 second). Both flow-inflating
bags and T-pieces may be used to consistently deliver inflations >
1 second. Although target inflation pressures and long inspiratory
times are achieved more consistently in mechanical models when
T-piece devices rather than bags are used, no recommendation can
be made as to which device is preferable (Wyckoff 2015; Wyllie
2015). Positive end-expiratory pressure (PEEP) is very important
for aerating the lungs and improving oxygenation; SLI consists of
prolonged high-level PEEP.
How the intervention might work
When airways are liquid-filled, it might be unnecessary to inter-
rupt inflation pressures to allow the lung to deflate and exhale CO2
(Hooper 2016). Boon 1979 described a study of 20 term infants
delivered byCaesarean section under general anaesthesia whowere
resuscitated with a T-piece via an ETT. Trial authors reported that
gas continued to flow through the flow sensor placed between the
T-piece and the ETT toward the infant at the end of a standard
inflation of 1 second on respiratory traces obtained (Boon 1979).
On the basis of this observation, this group performed a non-
randomised trial of sustained inflations given via a T-piece and
an ETT to nine term infants during delivery room resuscitation.
Investigators reported that initial inflation with a T-piece lasting
5 seconds produced a two-fold increase in inflation volume com-
pared with standard resuscitation techniques (Vyas 1981). Citing
these findings, a retrospective cohort study described the effects of
a change in management strategy for extremely low birth weight
infants in the delivery room (Lindner 1999). The new manage-
ment strategy included the introduction of an initial sustained in-
flation of 15 seconds obtained with a mechanical ventilator via a
nasopharyngeal tube. This change in strategy was associated with
a reduction in the proportion of infants intubated for ongoing
respiratory support without an apparent increase in adverse out-
comes. Pulmonary morbidity in very low birth weight infants was
reported to be related directly to mortality in 50% of cases of death
(Drew 1982). Moreover, multiple SLIs in very preterm infants im-
proved both heart rate and cerebral tissue oxygen saturation, in the
absence of any detrimental effects (Fuchs 2011). An observational
study showed that sustained inflation of 10 seconds at 25 cmH2O
in 70 very preterm infants at birth was not effective for infants
whowere not breathing, possibly owing to active glottic adduction
(van Vonderen 2014). Newly born infants frequently take a breath
and then prolong expiration via glottic closure and diaphragmatic
braking, giving themselves prolonged end-expiratory pressure.
Why it is important to do this review
Recommendations regarding use of sustained inflation at birth
have varied between international bodies. Although European Re-
suscitation Council guidelines suggest giving five inflation breaths
if the newborn is gasping or is not breathing (Wyllie 2015), the
American Heart Association states that evidence is insufficient to
recommend an optimum inflation time (Wyckoff 2015). Differ-
ences between these guidelines and their algorithms are intriguing
(Klingenberg 2016). A narrative review reported that sustained
inflation may reduce the need for mechanical ventilation among
preterm infants at risk for respiratory distress syndrome (RDS)
(Lista 2010). The same review showed that respiratory outcomes
among infants receiving sustained inflation (25 cmH2O for 15
seconds) were improved over those reported for an historical group
(Lista 2011).
This review updates the existing review “Sustained versus stan-
dard inflations during neonatal resuscitation to prevent mortal-
ity and improve respiratory outcomes”, which was published in
the Cochrane Database of Systematic Reviews in 2015 (O’Donnell
2015).
O B J E C T I V E S
To assess the efficacy of an initial sustained (> 1 second duration)
lung inflation (SLI) versus standard inflations (≤ 1 second) in
newborn infants receiving resuscitation with intermittent PPV.
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M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) and quasi-RCTs. We ex-
cluded observational studies (case-control studies, case series) and
cluster-RCTs.
Types of participants
Term and preterm infants resuscitated via PPV at birth.
Types of interventions
Interventions included resuscitation with initial sustained (> 1
second) inflation versus resuscitation with regular (≤ 1 second)
inflations:
• with no chest compressions as part of the initial
resuscitation (primary comparison); or
• with chest compressions as part of the initial resuscitation
(secondary comparison).
Types of outcome measures
Primary outcomes
• Death in the delivery room
• Death during hospitalisation
• Death to latest follow-up
Secondary outcomes
• Apgar scores at 1 and 5 minutes
• Heart rate at 5 minutes
• Endotracheal intubation in the delivery room
• Endotracheal intubation outside the delivery room during
hospitalisation
• Surfactant administration in the delivery room or during
hospital admission
• Need for mechanical ventilation
• Duration in hours of respiratory support (i.e. nasal
continuous airway pressure and ventilation via an ETT
considered separately and in total)
• Duration in days of supplemental oxygen requirement
• Chronic lung disease: need for supplemental oxygen at 28
days of life; need for supplemental oxygen at 36 weeks of
gestational age for infants born at or before 32 weeks of gestation
• Air leaks (pneumothorax, pneumomediastinum,
pneumopericardium, pulmonary interstitial emphysema)
reported individually or as a composite outcome
• Cranial ultrasound abnormalities: any intraventricular
haemorrhage (IVH), grade 3 or 4 according to the Papile
classification (Papile 1978), and cystic periventricular
leukomalacia
• Seizures including clinical and electroencephalographic
• Hypoxic ischaemic encephalopathy for term and late
preterm infants (grade 1 to 3 (Sarnat 1976))
• Long-term neurodevelopmental outcomes (rates of cerebral
palsy on physician assessment, developmental delay (i.e.
intelligence quotient (IQ) 2 standard deviations (SDs) < mean
on validated assessment tool (e.g. Bayley’s Mental
Developmental Index))
• Retinopathy of prematurity (ROP) (all stages and≥ stage 3)
• Patent ductus arteriosus (PDA) (pharmacological treatment
and surgical ligation)
Search methods for identification of studies
See Cochrane Neonatal Review Group (CNRG) search strategy.
Electronic searches
We used the criteria and standard methods of Cochrane and the
Cochrane Neonatal Review Group (see the Cochrane Neonatal
search strategy for specialized register).
We conducted a comprehensive search that included theCochrane
Central Register of Controlled Trials (CENTRAL; 2017, Issue
1) in the Cochrane Library; MEDLINE via PubMed (1966 to
17 February 2017); Embase (1980 to 17 February 2017); and
the Cumulative Index to Nursing and Allied Health Literature
(CINAHL) (1982 to 17 February 2017), using the following
search terms: (sustained inflation) OR (sustained AND inflation)
OR (sustained AND (inflat* AND (lung OR pulmonary))), plus
database-specific limiters for RCTs and neonates (see Appendix 1
for full search strategy for each database). We did not apply lan-
guage restrictions.
We searched clinical trials registries for ongoing and recently com-
pleted trials (clinicaltrials.gov; the World Health Organization
International Trials Registry and Platform - www.whoint/ictrp/
search/en/; and the ISRCTN Registry).
Searching other resources
We also searched abstracts of the Pediatric Academic Society (PAS)
from 2000 to 2017, electronically through the PAS website (
abstractsonline), using the following key words: “sustained infla-
tion” AND “clinical trial”.
Data collection and analysis
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Selection of studies
For this update, two review authors (MB, MGC) independently
screened all titles and abstracts to determine which trials met the
inclusion criteria. We retrieved full-text copies of all papers that
were potentially relevant.We resolved disagreements by discussion
between review authors.
Data extraction and management
Two review authors (MB, MGC) independently undertook data
abstraction using a data extraction form developed ad hoc and inte-
grated with a modified version of the Cochrane Effective Practice
andOrganisation of Care Group (EPOC) data collection checklist
(EPOC 2015).
We extracted the following characteristics from each included trial.
• Administrative details: study author(s); published or
unpublished; year of publication; year in which trial was
conducted; details of other relevant papers cited.
• Trial details: study design; type, duration, and completeness
of follow-up; country and location of study; informed consent;
ethics approval.
• Details of participants: birth weight; gestational age;
number of participants.
• Details of intervention: type of ventilation device used; type
of interface; duration and level of pressure of sustained lung
inflation (SLI).
• Details of outcomes: death during hospitalisation or to
latest follow-up; heart rate at 5 minutes; duration in hours of
respiratory support; duration in days of supplemental oxygen
requirement; long-term neurodevelopmental outcomes; any
adverse events.
We resolved disagreements by discussion between review authors.
When available, we described ongoing trials identified by detail-
ing primary trial author, research question(s) posed, and methods
and outcome measures applied, together with an estimate of the
reporting date.
When queries arose or additional data were required, we contacted
trial authors.
Assessment of risk of bias in included studies
Two review authors (MB, SZ) independently assessed risk of bias
(low, high, or unclear) of all included trials using the Cochrane
‘Risk of bias’ tool (Higgins 2011) for the following domains.
• Sequence generation (selection bias).
• Allocation concealment (selection bias).
• Blinding of participants and personnel (performance bias).
• Blinding of outcome assessment (detection bias).
• Incomplete outcome data (attrition bias).
• Selective reporting (reporting bias).
• Any other bias.
We resolved disagreements by discussion or via consultation with
a third assessor. See Appendix 2 for a detailed description of risk
of bias for each domain.
Selection bias (random sequence generation and allocation
concealment)
Random sequence generation
For each included trial, we categorised risk of bias regarding ran-
dom sequence generation as follows.
• Low risk - adequate (any truly random process, e.g. random
number table; computer random number generator).
• High risk - inadequate (any non-random process, e.g. odd
or even date of birth; hospital or clinic record number).
• Unclear risk - no or unclear information provided.
Allocation concealment
For each included trial, we categorised risk of bias regarding allo-
cation concealment as follows.
• Low risk - adequate (e.g. telephone or central
randomisation; consecutively numbered sealed opaque
envelopes).
• High risk - inadequate (open random allocation; unsealed
or non-opaque envelopes, alternation; date of birth).
• Unclear risk - no or unclear information provided.
Performance bias
Owing to the nature of the intervention, all trials were unblinded,
leading to high risk of performance bias.
Detection bias
For each included trial, we categorised the methods used to blind
outcome assessors from knowledge of which intervention a partic-
ipant received. We assessed blinding separately for different out-
comes or different classes of outcomes.
Attrition bias
For each included trial and for each outcome, we described com-
pleteness of data including attrition and exclusions from analysis.
We noted whether attrition and exclusions were reported, num-
bers included in the analysis at each stage (compared with the to-
tal number of randomised participants), reasons for attrition or
exclusion when reported, and whether missing data were balanced
across groups or were related to outcomes.
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Reporting bias
For each included trial, we described how we investigated the
risk of selective outcome reporting bias and what we found. We
assessed methods as follows.
• Low risk - adequate (when it is clear that all of a trial’s
prespecified outcomes and all expected outcomes of interest to
the review have been reported).
• High risk - inadequate (when not all of a trial’s prespecified
outcomes have been reported; one or more reported primary
outcomes were not prespecified; outcomes of interest were
reported incompletely and so cannot be used; or the trial failed
to include results of a key outcome that would have been
expected to be reported).
• Unclear risk - no or unclear information provided (study
protocol was not available).
Other bias
For each included trial, we described any important concerns that
we had about other possible sources of bias (e.g. whether a potential
source of bias was related to the specific trial design, whether the
trial was stopped early owing to some data-dependent process).
We assessed whether each trial was free of other problems that
could put it at risk of bias as follows.
• Low risk - no concerns of other bias raised.
• High risk - concerns raised about multiple looks at data
with results made known to investigators, differences in numbers
of participants enrolled in abstract, and final publications of the
paper.
• Unclear - concerns raised about potential sources of bias
that could not be verified by contacting trial authors.
We did not score blinding of the intervention because this was not
applicable.
One review author entered data into RevMan 2014, and a second
review author checked entered data for accuracy.
Measures of treatment effect
We conducted measures of treatment effect data analysis using
RevMan 2014. We determined outcome measures for dichoto-
mous data (e.g. death, endotracheal intubation in the delivery
room, frequency of retinopathy) as risk ratios (RRs) with 95%
confidence intervals (CIs).We calculated continuous data (e.g. du-
ration of respiratory support, Apgar score) using mean differences
(MDs) and SDs.
Unit of analysis issues
The unit of randomisation was the intended unit of analysis (in-
dividual neonate).
Dealing with missing data
We contacted trial authors to request missing data when needed.
Assessment of heterogeneity
As a measure of consistency, we used the I² statistic and the Q
(Chi²) test (Deeks 2011). We judged statistical significance of the
Q (Chi²) statistic by P < 0.10 because of the low statistical power
of the test. We used the following cut-offs for heterogeneity: <
25% no (none) heterogeneity; 25% to 49% low heterogeneity;
50% to 74% moderate heterogeneity; and ≥ 75% high hetero-
geneity (Higgins 2003). We combined trial results using the fixed-
effect model, regardless of statistical evidence of heterogeneity ef-
fect sizes.
Assessment of reporting biases
See Appendix 2.
Data synthesis
We performed statistical analyses using RevMan 2014. We used
the standard methods of the Cochrane Neonatal Review Group.
For categorical data, we used RRs, relative risk reductions, and
absolute risk difference (RDs). We obtained means and SDs for
continuous data and performed analyses using MDs and WMDs
when appropriate.We calculated 95%CIs.Wepresented the num-
ber needed to treat for an additional beneficial outcome (NNTB)
and the number needed to treat for an additional harmful outcome
(NNTH), as appropriate. For each comparison reviewed, meta-
analysis could be feasible if we identified more than one eligible
trial, and if homogeneity among trials was sufficient with respect
to participants and interventions. We combined trials using the
fixed-effect model, regardless of statistical evidence of heterogene-
ity effect sizes. For estimates of RR and RD, we used the Mantel-
Haenszel method.
Quality of evidence
We used the Grading of Recommendations Assessment, Devel-
opment, and Evaluation (GRADE) approach, as outlined in the
GRADE Handbook (Schünemann 2013), to assess the quality of
evidence for the following (clinically relevant) outcomes: death in
the delivery room or during hospitalisation; endotracheal intuba-
tion in the delivery room or outside the delivery room during hos-
pitalisation; surfactant administration in the delivery room or dur-
ing hospital admission; need for mechanical ventilation; chronic
lung disease; air leaks; and cranial ultrasound abnormalities.
Two review authors independently assessed the quality of evidence
for each of the outcomes above. We considered evidence from
RCTs as high quality but downgraded evidence one level for seri-
ous (or two levels for very serious) limitations on the basis of the
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following: design (risk of bias), consistency across studies, direct-
ness of evidence, precision of estimates, and presence of publica-
tion bias. We used the GRADEproGDTGuideline Development
Tool to create a ‘Summary of findings’ table to report the quality
of evidence.
The GRADE approach yields an assessment of the quality of a
body of evidence according to one of four grades.
• High: We are very confident that the true effect lies close to
that of the estimate of the effect.
• Moderate: We are moderately confident in the effect
estimate: The true effect is likely to be close to the estimate of the
effect, but there is a possibility that it is substantially different.
• Low: Our confidence in the effect estimate is limited: The
true effect may be substantially different from the estimate of the
effect.
• Very low: We have very little confidence in the effect
estimate: The true effect is likely to be substantially different
from the estimate of effect.
Subgroup analysis and investigation of heterogeneity
We planned to perform the following subgroup analyses of the
safety and efficacy of sustained inflation during resuscitation in
subgroups.
• Term (≥ 37 weeks of gestation) and preterm (< 37 weeks of
gestation) infants.
• Type of ventilation device used (self-inflating bag, flow-
inflating bag, T-piece, mechanical ventilator).
• Interface used (i.e. face mask, ETT, nasopharyngeal tube).
• Duration of sustained lung inflation (i.e. > 1 second to 5
seconds, > 5 seconds).
Sensitivity analysis
Weplanned to conduct sensitivity analyses to explore effects of the
methodological quality of trials and checked to ascertain whether
studies with high risk of bias overestimated treatment effects.
R E S U L T S
Description of studies
We have provided results of the search for this review update in
the study flow diagram (Figure 1).
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Figure 1. Study flow diagram: review update.
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See Characteristics of included studies, Characteristics of excluded
studies, and Characteristics of ongoing studies sections for details.
Included studies
Eight trials recruiting 941 infants (473 in SLI groups, 468 in con-
trol groups) met the inclusion criteria (El-Chimi 2017; Jiravisitkul
2017; Lindner 2005; Lista 2015; Mercadante 2016; Ngan 2017;
Schmölzer 2015; Schwaberger 2015).We pooled seven trials (with
932 infants) in the primary comparison (i.e. use of sustained in-
flation with no chest compressions) (El-Chimi 2017; Jiravisitkul
2017; Lindner 2005; Lista 2015; Mercadante 2016; Ngan 2017;
Schwaberger 2015). In contrast to other trials, Schwaberger 2015
sought to use near-infrared spectroscopy (NIRS) to investigate
whether SLI affected physiological changes in cerebral blood vol-
ume and oxygenation. We could not perform any meta-analysis in
the secondary comparison (intervention superimposed on unin-
terrupted chest compressions) because we included only one trial
(a pilot study of nine preterm infants) (Schmölzer 2015).
We have listed characteristics of populations and interventions and
comparisons of the eight trials under Characteristics of included
studies and in Table 1.
Settings and populations
Researchers conducted the included studies on four different con-
tinents: two in Italy (Lista 2015;Mercadante 2016), two inCanada
by the same contact author (Ngan 2017; Schmölzer 2015), one
in Germany (Lindner 2005), one in Austria (Schwaberger 2015),
one in Egypt (El-Chimi 2017), and one in Thailand (Jiravisitkul
2017). Only one study was conducted at multiple centres (Lista
2015). Five of the six trials identified for this update included in-
fants with mean birth weight > 1 kg (El-Chimi 2017; Jiravisitkul
2017;Mercadante 2016;Ngan 2017; Schwaberger 2015), whereas
the two previously included studies (Lindner 2005; Lista 2015)
and the pilot trial (Schmölzer 2015) enrolled extremely low birth
weight infants. Mercadante 2016 was the only trial conducted in
late preterm infants. No trials enrolled full-term infants. Table 1
shows additional information on populations.
Interventions
Trials pooled in the primary comparison (i.e. without chest com-
pressions) reported that peak inspiratory pressure (PIP) was sus-
tained for 15 seconds in six trials (El-Chimi 2017; Jiravisitkul
2017; Lindner 2005; Lista 2015; Mercadante 2016; Schwaberger
2015) and for 20 seconds in Ngan 2017. However, levels of
PIP ranged from 20 cmH2O (El-Chimi 2017; Lindner 2005) to
24 (Ngan 2017), 25 (Jiravisitkul 2017; Lista 2015; Mercadante
2016), and 30 cmH2O (Schwaberger 2015). Investigators pro-
vided additional SLIs in cases of poor response, with the same
(Jiravisitkul 2017;Mercadante 2016; Schwaberger 2015) or higher
PIP (El-Chimi 2017; Lindner 2005); researchers in Ngan 2017
based the duration of the second SLI on exhaled CO2 values. As
regards interface and ventilation devices, most included trials used
mask and T-piece. However, Lindner 2005 used nasopharyngeal
tube and ventilator, and El-Chimi 2017 introduced a relevant bias
into the study design by using a T-piece ventilator in the SLI
group and a self-inflating bag in the control group (mask in both
SLI and control groups). No trials reported whether prespecified
levels of pressure for the SLI were actually delivered according to
the protocol. Study authors did not monitor leaks at the mask and
lung volumes during the manoeuvre. Whether the infant breathed
before or during the SLI was not recorded: Apnoeic newborns at
birth are known to show less gain in lung volume during an SLI
than actively breathing infants (Lista 2017).
For the secondary comparison, in which infants in both SLI and
control groupswere resuscitatedwith chest compressions, duration
of SLI was 20 + 20 seconds (Schmölzer 2015).
Table 1 shows additional information on interventions.
Excluded studies
We have summarised the reasons for exclusion of potentially el-
igible trials (Bouziri 2011; Harling 2005; te Pas 2007) in the
Characteristics of excluded studies table.
In particular, we excluded te Pas 2007 because sustained inflation
was only one element of the intervention, and because it is not
possible to determine the relative contributions of various elements
of this intervention to differences observed between groups. We
excludedHarling 2005, as investigators randomised infants in this
trial to receive inflation for 2 seconds or 5 seconds at initiation of
PPV. All infants thus received sustained (> 1 second) inflations as
defined in our protocol (O’Donnell 2004).
For the 2017 update, we excluded no eligible studies.
Risk of bias in included studies
We have presented a summary of the ’Risk of bias’ assessment in
Figure 2 and Figure 3. We have provided details of the method-
ological quality of included trials in the Characteristics of included
studies section.
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
trial.
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Figure 3. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included trials.
Allocation
One trial had high risk of selection bias: This quasi-randomised
trial (odd-numbered sheets indicated allocation to the SLI group,
and even-numbered sheets to the control group) did not use
opaque envelopes (information provided by study authors) (El-
Chimi 2017). In Jiravisitkul 2017 and Schwaberger 2015, risk of
selection bias was low as regards random sequence generation and
allocation concealment (opaque, numbered envelopes). In Ngan
2017, risk of selection bias was low as regards random sequence
generation and was unclear for allocation concealment: Timing of
randomisation resulted in many post-randomisation exclusions,
as results showed more post-randomisation exclusions in the SLI
group than in the control group. In the other four trials, risk of
selection bias was unclear as regards random sequence generation
and was low as regards allocation concealment (opaque, num-
bered envelopes) (Lindner 2005; Lista 2015; Mercadante 2016;
Schmölzer 2015).
Blinding
Owing to the nature of the intervention, all trials were unblinded,
leading to high risk of performance bias. However, four trials
blinded researchers assessing trial endpoints to the nature of study
treatments (Lista 2015;Mercadante 2016; Ngan 2017; Schmölzer
2015).
Incomplete outcome data
El-Chimi 2017 referred almost half of enrolled infants to other
NICUs; we excluded these studies from analysis owing to failure of
follow-up, although the primary outcome of the study (treatment
failure/success within 72 hours) could have been determined and
reported for these infants. In Ngan 2017, post-randomisation ex-
clusion (27%) resulted in fewer included infants in the SLI group.
Most trials accounted for all outcomes (Lindner 2005; Lista 2015;
Mercadante 2016; Schwaberger 2015).
Selective reporting
Four trials provided complete results for all reported outcomes
(Lindner 2005; Lista 2015; Ngan 2017; Schwaberger 2015).
Other potential sources of bias
El-Chimi 2017 and Schwaberger 2015 did not report sample size
calculations. For Schwaberger 2015, investigators registered the
protocol after study initiation. Jiravisitkul 2017 planned sample
sizes of 40 infants for each group but allocated only 38 to the con-
trol group. Lindner 2005 was stopped after the interim analysis.
It was unclear why study authors made this decision. Ngan 2017
did not achieve the planned sample size; in addition, the incidence
of the primary outcome in the control group was less than that
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assumed for the sample size calculation, leading to lack of power
to detect the chosen effect size. The other trials appear free of other
bias.
We were unable to explore possible bias through generation of
funnel plots because fewer than ten trials met the inclusion criteria
of this Cochrane review.
Effects of interventions
See:Summary of findings for themain comparisonUse of initial
sustained inflation compared with standard inflations in newborns
receiving resuscitation with no chest compressions during
resuscitation; Summary of findings 2 Use of initial sustained
inflation compared with standard inflations in newborns receiving
resuscitation with chest compressions during resuscitation
Primary comparison: use of initial sustained inflation
versus standard inflations in newborns receiving
resuscitation with no chest compressions
Primary outcomes
Death (Outcome 1.1)
Death in the delivery room (Outcome 1.1.1)
Five trials (N = 479) reported this outcome (El-Chimi 2017;
Jiravisitkul 2017; Lindner 2005; Mercadante 2016; Schwaberger
2015); one event occurred in the SLI group in Jiravisitkul 2017
(death in delivery room at 15 to 20 minutes of life, severe birth
asphyxia as the result of a prolapsed cord), and none in the other
four trials (typical RR 2.66, 95% CI 0.11 to 63.40; typical RD
0.00, 95% CI -0.02 to 0.02; participants = 479; studies = 5; I² not
applicable for RR and I² = 0% for RD; Analysis 1.1 and Figure
4). We obtained data for this outcome directly from trial authors
(Jiravisitkul 2017; Lindner 2005).
Figure 4. Forest plot of comparison: 1 Use of initial sustained inflation vs standard inflations in newborns
receiving resuscitation with no chest compressions, outcome: 1.1 Death.
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Death during hospitalisation (Outcome 1.2.1)
All trials included in the primary comparison (El-Chimi 2017;
Jiravisitkul 2017; Lindner 2005; Lista 2015; Mercadante 2016;
Ngan 2017; Schwaberger 2015) reported mortality during hos-
pitalisation (typical RR 1.01, 95% CI 0.67 to 1.51; typical RD
0.00, 95% CI -0.03 to 0.03; participants = 932; studies = 7; I² =
19% for RR and I² = 0% for RD; Analysis 1.1 and Figure 4).
We obtained data for this outcome directly from trial authors
(El-Chimi 2017; Jiravisitkul 2017; Lindner 2005).
In El-Chimi 2017, 12 and 19 infants in SLI and control groups,
respectively, died. In Jiravisitkul 2017, two infants in each group
died: In the SLI group, one died of severe birth asphyxia as the
result of a prolapsed cord, and the other died at 3 hours of life of
suspected umbilical catheter migration with haemothorax; in the
control group, one died of severe respiratory distress syndrome at
2 hours of life, and the other of septic shock at 168 days of life.
In Lindner 2005, three deaths occurred in the sustained inflation
group: at day 1 (respiratory failure), at day 36 (necrotising ente-
rocolitis), and at day 107 (liver fibrosis of unknown origin). In
Lista 2015, 12 infants in the control group and 17 in the sus-
tained inflations group died during the trial. Mercadante 2016
and Schwaberger 2015 reported no events.
Secondary outcomes
Apgar score at one minute (Outcome 1.2)
Five trials (N = 529) (Jiravisitkul 2017; Lindner 2005;Mercadante
2016; Ngan 2017; Schwaberger 2015) reported this outcome
(MD -0.08, 95% CI -0.26 to 0.09; participants = 529; studies = 5;
I² = 0%; Analysis 1.2).We obtained data for this outcome directly
from trial authors (Jiravisitkul 2017; Lindner 2005; Mercadante
2016; Ngan 2017; Schwaberger 2015).
Apgar score at five minutes (Outcome 1.3)
Six trials (N = 641) (El-Chimi 2017; Jiravisitkul 2017; Lindner
2005;Mercadante 2016;Ngan 2017; Schwaberger 2015) reported
this outcome (MD -0.02, 95% CI -0.13 to 0.08; participants =
641; studies = 6; I² = 46%; Analysis 1.3).We obtained data for this
outcome directly from trial authors (El-Chimi 2017; Jiravisitkul
2017; Lindner 2005;Mercadante 2016; Ngan 2017; Schwaberger
2015).
Endotracheal intubation (Outcome 1.4)
Endotracheal intubation in the delivery room (Outcome
1.4.1)
Five trials (N = 601) (El-Chimi 2017; Jiravisitkul 2017; Lindner
2005;Mercadante 2016; Ngan 2017) reported this outcome (typ-
ical RR 0.86, 95% CI 0.62 to 1.19; typical RD -0.03, 95% CI -
0.08 to 0.03; participants = 601; studies = 5; I² = 64% for RR and
I² = 74% for RD; Analysis 1.4; Figure 5). We obtained data for
this outcome directly from trial authors (Mercadante 2016).
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Figure 5. Forest plot of comparison: 1 Use of initial sustained inflation vs standard inflations in newborns
receiving resuscitation with no chest compressions, outcome: 1.4 Endotracheal intubation.
Endotracheal intubation outside the delivery room within 24
hours (Outcome 1.4.2)
Two trials (N = 225) (Mercadante 2016; Schwaberger 2015) re-
ported this outcome (RR 1.40, 95% CI 0.53 to 3.68; RD 0.02,
95%CI -0.04 to 0.07; participants = 225; studies = 2). The test for
heterogeneity was not applicable because only one trial (Lindner
2005) reported events (Analysis 1.4; Figure 5). We obtained data
for this outcome directly from trial authors (Mercadante 2016).
Endotracheal intubation outside the delivery room by 72
hours (Outcome 1.4.3)
Five included trials (N = 811) (El-Chimi 2017; Lindner 2005;
Lista 2015; Mercadante 2016; Ngan 2017) reported this outcome
(typical RR 0.93, 95% CI 0.79 to 1.09; typical RD -0.03, 95%
CI -0.09 to 0.03; participants = 811; studies = 5; I² = 0% for RR
and I² = 53% for RD) (Analysis 1.4; Figure 5). We obtained data
for this outcome directly from trial authors (Mercadante 2016).
Surfactant administration (Outcome 1.5)
Surfactant administration in the delivery room (Outcome
1.5.1)
Three trials (N = 335) (El-Chimi 2017; Lindner 2005; Ngan
2017) reported this outcome (typical RR 1.43, 95% CI 0.82 to
2.49; typical RD 0.04, 95% CI -0.02 to 0.11; participants = 335;
studies = 3; I² = 0% for RR and I² = 72% for RD; Analysis 1.5;
Figure 6). We obtained data for this outcome directly from trial
authors (El-Chimi 2017).
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Figure 6. Forest plot of comparison: 1 Use of initial sustained inflation vs standard inflations in newborns
receiving resuscitation with no chest compressions, outcome: 1.5 Surfactant administration.
Surfactant administration during hospital admission
(Outcome 1.5.2)
All trials included in the primary comparison (El-Chimi 2017;
Jiravisitkul 2017; Lindner 2005; Lista 2015; Mercadante 2016;
Ngan 2017; Schwaberger 2015) (N = 932) reported this outcome
(typical RR 0.97, 95% CI 0.86 to 1.10; typical RD -0.01, 95%
CI -0.06 to 0.04; participants = 932; studies = 7; I² = 0% for RR
and I² = 0% for RD; Analysis 1.5; Figure 6). We obtained data for
this outcome directly from trial authors (El-Chimi 2017; Lindner
2005; Mercadante 2016).
Need for mechanical ventilation (Outcome 1.6)
Three trials (N = 484) reported this outcome (El-Chimi 2017;
Jiravisitkul 2017; Lista 2015) (typical RR 0.87, 95% CI 0.74 to
1.03; typical RD -0.06, 95% CI -0.14 to 0.01; participants = 484;
studies = 3; I² = 0% for RR and I² = 85% for RD) (Analysis
1.6).We obtained data for this outcome directly from trial authors
(El-Chimi 2017).
Duration of nasal continuous airway pressure (Outcome 1.7)
Three trials (N = 355) reported this outcome (El-Chimi 2017;
Lindner 2005; Mercadante 2016) (MD 0.26 days, 95% CI -0.19
to 0.72; participants = 355; studies = 3; I² = 59%) (Analysis 1.7).
We obtained data for this outcome directly from trial authors; data
for this outcome refer to survivors at time of assessment (El-Chimi
2017; Lindner 2005; Mercadante 2016).
Duration of ventilation via an ETT (Outcome 1.8)
Five trials (N = 524) reported this outcome (Jiravisitkul 2017;
Lindner 2005;Mercadante 2016; Ngan 2017; Schwaberger 2015)
(MD -5.37 days, 95% CI -6.31 to -4.43; participants = 524; stud-
ies = 5; I² = 95%; Analysis 1.8). Data for this outcome refer to
survivors at time of assessment (Jiravisitkul 2017; Lindner 2005;
Mercadante 2016). We obtained data for this outcome directly
from trial authors (Jiravisitkul 2017; Mercadante 2016; Ngan
2017; Schwaberger 2015). Heterogeneity, statistical significance,
and magnitude of effects of this outcome are largely influenced by
a single study (Ngan 2017): when this study was removed from
the analysis, the effect was largely reduced (MD -1.71 days, 95%
CI -3.04 to -0.39, I² = 0%).
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Duration of respiratory support (nasal continuous airway
pressure and ventilation via an ETT, considered in total)
(Outcome 1.9)
Two trials (N = 243) reported this outcome (Lindner 2005;
Mercadante 2016) (MD 0.69 days, 95% CI 0.23 to 1.16; partici-
pants = 243; studies = 2; I² = 0%; Analysis 1.9). We obtained data
for this outcome directly from trial authors; data refer to survivors
at time of assessment (Lindner 2005; Mercadante 2016).
Duration of supplemental oxygen requirement (days)
(Outcome 1.10)
One trial (N = 81) reported this outcome (Jiravisitkul 2017)
(MD -9.73, 95% CI -25.06 to 5.60; participants = 81; studies
= 1; Analysis 1.10). The test for heterogeneity was not applica-
ble. We obtained data for this outcome directly from trial authors
(Jiravisitkul 2017).
Chronic lung disease (i.e. need for supplemental oxygen at
36 weeks of gestational age for infants born at or before 32
weeks of gestation) (Outcome 1.11)
Bronchopulmonary dysplasia (BPD) any grade (Outcome
1.11.1)
Two trials (N = 220) reported this outcome (Lindner 2005; Ngan
2017) (typical RR 0.90, 95% CI 0.69 to 1.19; typical RD -0.05,
95% CI -0.17 to 0.08; participants = 220; studies = 2; I² = 0%
for RR and I² = 0% for RD). We obtained data for this outcome
directly from trial authors; data refer to survivors at time of assess-
ment (Lindner 2005; Analysis 1.11).
Moderate to severe BDP (Outcome 1.11.2)
Five included trials (N = 683) (El-Chimi 2017; Jiravisitkul 2017;
Lista 2015;Ngan 2017; Schwaberger 2015) reported this outcome
(typical RR 0.95, 95% CI 0.74 to 1.22; typical RD -0.01, 95%
CI -0.07 to 0.05; participants = 683; studies = 5; I² = 47% for RR
and I² = 57% for RD; Analysis 1.11).
Air leaks (pneumothorax, pneumomediastinum,
pneumopericardium, pulmonary interstitial emphysema)
reported individually or as a composite outcome (Outcome
1.12)
Pneumothorax in first 48 hours of life (Outcome 1.12.1)
One trial (N = 81) (Jiravisitkul 2017) reported this outcome (RR
0.88, 95% CI 0.06 to 13.65; RD -0.00, 95% CI -0.07 to 0.06).
The test for heterogeneity was not applicable (Analysis 1.12).
Pneumothorax at any time (Outcome 1.12.2)
Six included studies (N = 851) (El-Chimi 2017; Lindner 2005;
Lista 2015; Mercadante 2016; Ngan 2017; Schwaberger 2015)
reported this outcome (typical RR 1.44, 95% CI 0.76 to 2.72;
typical RD 0.02, 95% CI -0.01 to 0.04; studies = 6; 851 infants;
I² = 26% for RR and I² = 2% for RD; Analysis 1.12).
Cranial ultrasound abnormalities (Outcome 1.13)
Intraventricular haemorrhage (IVH), grade 3 or 4 according
to the Papile classification (Papile 1978) (Outcome 1.13.1)
Five included trials (N = 635) (Jiravisitkul 2017; Lindner 2005;
Lista 2015;Ngan 2017; Schwaberger 2015) reported this outcome
(typical RR 0.89, 95% CI 0.58 to 1.37; typical RD -0.01, 95%
CI -0.06 to 0.03; studies = 5; 635 infants; I2 = 4% for RR and I2
= 0% for RD; Analysis 1.13).
IVH any grade (Outcome 1.13.2)
Two included trials (N=152) (El-Chimi 2017; Schwaberger 2015)
reported this outcome (typical RR 0.82, 95% CI 0.40 to 1.69;
typical RD -0.03, 95% CI -0.15 to 0.08; studies = 3; 152 infants;
I² = 0% for RR and I² = 0% for RD; Analysis 1.13).
Cystic periventricular leukomalacia (Outcome 1.13.3)
Five included trials (N = 635) (Jiravisitkul 2017; Lindner 2005;
Lista 2015;Ngan 2017; Schwaberger 2015) reported this outcome
(typical RR 0.59, 95% CI 0.24 to 1.44; typical RD -0.04, 95%
CI -0.04 to 0.01; studies = 5; 635 infants; I² = 0% for RR and I²
= 0% for RD; Analysis 1.13).
Retinopathy of prematurity (ROP) ≥ stage 3 (Outcome 1.14)
Five trials (N = 632) (Jiravisitkul 2017; Lindner 2005; Lista 2015;
Ngan 2017; Schwaberger 2015) reported this outcome (typical
RR 0.69, 95% CI 0.44 to 1.10; typical RD -0.04, 95% CI -0.08
to 0.01; studies = 5; 632 infants; I² = 42% for RR and I² = 40%
for RD; Analysis 1.14). For Lindner 2005, data refer to survivors
at time of assessment (Analysis 1.14).
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Patent ductus arteriosus (PDA) (Outcome 1.15)
Rate of PDA - pharmacological treatment (Outcome 1.15.1)
Six included trials (N = 745) (El-Chimi 2017; Jiravisitkul 2017;
Lindner 2005; Lista 2015; Ngan 2017; Schwaberger 2015) re-
ported this outcome (typical RR 1.08, 95% CI 0.90 to 1.30; typ-
ical RD 0.03, 95% CI -0.04 to 0.09; studies = 6; 745 infants; I²
= 36% for RR and I² = 58% for RD; Analysis 1.15). We obtained
data for this outcome directly from trial authors (Schwaberger
2015).
Rate of PDA - surgical closure (Outcome 1.15.2)
Three trials (N = 412) (Jiravisitkul 2017; Lista 2015; Schwaberger
2015) reported this outcome (typical RR 0.73, 95% CI 0.27 to
1.99; typical RD -0.01, 95% CI -0.05 to 0.03; studies = 3; 412
infants; I² = 0% for RR and I² = 26% for RD; Analysis 1.15).
We obtained data for this outcome directly from trial authors
(Schwaberger 2015).
The data refer to all randomised infants, unless otherwise specified.
No data were reported for the following outcomes: heart rate; need
for supplemental oxygen at 28 days of life; seizures including clini-
cal and electroencephalographic; hypoxic ischaemic encephalopa-
thy in term and late preterm infants (grade 1 to 3; Sarnat 1976);
and long-term neurodevelopmental outcomes.
Death to latest follow-up: No data were provided in addition to
those already presented for death during hospitalisation (Analysis
1.1).
Subgroup analysis for the primary comparison
For the primary comparison, we were unable to conduct any of
the four prespecified subgroup analyses because:
• no term infants were included;
• for ventilation devices, all trials used a T-piece except
Lindner 2005 (mechanical ventilator): We did not perform a
separate analysis because of the very small sample size and the
presence of high or unclear risk of bias in most GRADE
domains. Moreover, El-Chimi 2017 used a T-piece ventilator in
the SLI group and a self-inflating bag in the control group; thus
we could not include this as a subgroup;
• for interface, all trials used a face mask, except Lindner
2005 (nasopharyngeal tube): As for ventilation devices, we did
not perform a separate analysis for Lindner 2005; and
• no trials used SLI < 5 seconds.
Secondary comparison: use of initial sustained
inflation versus standard inflations in newborns
receiving resuscitation with chest compressions
Primary outcomes
Death (Outcome 2.1)
Death in the delivery room (Outcome 2.1.1)
The included trial (N = 9) did not report this outcome (Schmölzer
2015).
Death during hospitalisation (Outcome 2.1.2)
One trial (N = 9) reported this outcome (RR 1.60, 95% CI 0.21
to 11.92; RD 0.15, 95% CI -0.45 to 0.75); thus, the test for
heterogeneity was not applicable for this outcome (Schmölzer
2015; Analysis 2.1). We obtained data for this outcome directly
from trial authors (Schmölzer 2015).
Secondary outcomes
Endotracheal intubation in the delivery room (Outcome 2.2)
One trial (N = 9) reported this outcome (RR 1.00, 95% CI 0.68
to 1.46; RD 0.00, 95% CI -0.34 to 0.34); thus, the test for het-
erogeneity was not applicable for this outcome (Schmölzer 2015;
Analysis 2.2). We obtained data for this outcome directly from
trial authors (Schmölzer 2015).
Surfactant administration in the delivery room (Outcome
2.3)
One trial (N = 9) reported this outcome (RR 1.60, 95% CI 0.55
to 4.68; RD 0.30, 95% CI -0.30 to 0.90); thus, the test for het-
erogeneity was not applicable for this outcome (Schmölzer 2015;
Analysis 2.3). We obtained data for this outcome directly from
trial authors (Schmölzer 2015).
Chronic lung disease (2.4, 2.5, 2.6)
Moderate to severe BDP (Outcome 2.4)
One trial (N = 9) reported this outcome (RR 0.89, 95% CI 0.33
to 2.37; RD -0.08, 95% CI -0.76 to 0.60); thus, the test for
heterogeneity was not applicable for this outcome (Schmölzer
2015; Analysis 2.3). We obtained data for this outcome directly
from trial authors (Schmölzer 2015).
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Pneumothorax at any time (Outcome 2.5)
One trial (N = 9) reported this outcome: No events occurred
(Analysis 2.5). We obtained data for this outcome directly from
trial authors (Schmölzer 2015).
Cranial ultrasound abnormalities (Outcome 2.6)
Intraventricular haemorrhage (IVH), grade 3 or 4 according to
the Papile classification (Papile 1978) (Outcome 2.6.1)
One trial (N = 9) reported this outcome (RR 0.40, 95% CI 0.05
to 2.98; RD -0.30, 95% CI -0.90 to 0.30); thus, the test for
heterogeneity was not applicable for this outcome (Schmölzer
2015; Analysis 2.6). We obtained data for this outcome directly
from trial authors (Schmölzer 2015).
IVH any grade (Outcome 2.6.2)
One trial (N = 9) reported this outcome (RR 0.28, 95% CI 0.07
to 1.15; RD -0.80, 95% CI -1.23 to -0.37); thus, the test for
heterogeneity was not applicable for this outcome (Schmölzer
2015; Analysis 2.6). We obtained data for this outcome directly
from trial authors (Schmölzer 2015).
Retinopathy of prematurity (ROP) ≥ stage 3 (Outcome 2.7)
One trial (N = 9) reported this outcome (RR 0.27, 95% CI 0.04
to 1.68; RD -0.55, 95% CI -1.10 to 0.00); thus, the test for
heterogeneity was not applicable for this outcome (Schmölzer
2015; Analysis 2.7). We obtained data for this outcome directly
from trial authors (Schmölzer 2015).
Rate of PDA - pharmacological treatment (Outcome 2.8)
One trial (N = 9) reported this outcome (RR 0.46, 95% CI 0.17
to 1.25; RD -0.60, 95% CI -1.07 to -0.13); thus, the test for
heterogeneity was not applicable for this outcome (Schmölzer
2015; Analysis 2.8). We obtained data for this outcome directly
from trial authors (Schmölzer 2015).
For the secondary comparison, investigators provided no data on
other prespecified outcomes.
Subgroup analysis for the secondary comparison
For the secondary comparison, we were unable to conduct any
subgroup analysis, as we included only one trial.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Use of initial sustained inflation compared with standard inflations in newborns receiving resuscitation with chest compressions during resuscitation
Patient or population: preterm infants resuscitated by PPV at birth
Settings: delivery room in Europe (Austria, Germany, Italy), Canada, Egypt, Thailand
Intervention: sustained inf lat ion with chest compressions
Comparison: standard inf lat ions with chest compressions
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No. of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Standard inflations in
newborns receiving re-
suscitation with chest
compressions
Use of initial sustained
inflation
Death - death before
discharge
See comment See comment Not est imable 9
(1 study)
⊕©©©
very lowa,b
Only 1 trial included
Chronic lung disease
- moderate to severe
BPD
See comment See comment Not est imable 7
(1 study)
⊕©©©
very lowa,b
Only 1 trial included
Pneumothorax - any
time
See comment See comment Not est imable 9
(1 study)
⊕©©©
very lowa,b
Only 1 trial included
Cranial ultrasound ab-
normalities - intraven-
tricular haemorrhage
grade 3 to 4
See comment See comment Not est imable 9
(1 study)
⊕©©©
very lowa,b
Only 1 trial included
* The basis for the assumed risk (e.g. median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is based on
the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI)
CI: conf idence interval
2
2
S
u
sta
in
e
d
v
e
rsu
s
sta
n
d
a
rd
in
fl
a
tio
n
s
d
u
rin
g
n
e
o
n
a
ta
l
re
su
sc
ita
tio
n
to
p
re
v
e
n
t
m
o
rta
lity
a
n
d
im
p
ro
v
e
re
sp
ira
to
ry
o
u
tc
o
m
e
s
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
1
7
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate
Very low quality: We are very uncertain about the est imate
Assumed risk is the risk of the control arm.
aLim itat ions in study design: included study at high or unclear risk of bias in four domains
bImprecision (downgraded by two levels): extremely low sample size, few events
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D I S C U S S I O N
Summary of main results
We evaluated themerits of sustained lung inflation (SLI) versus in-
termittent ventilation in infants requiring resuscitation and stabil-
isation at birth. Eight trials enrolling 941 preterm infants met re-
view inclusion criteria (El-Chimi 2017; Jiravisitkul 2017; Lindner
2005; Lista 2015; Mercadante 2016; Ngan 2017; Schmölzer
2015; Schwaberger 2015). Whereas the two trials included in
the previous version of this review enrolled infants at 25+0 to
28+6 weeks (Lindner 2005; Lista 2015), the five more recent
trials enrolled larger infants (El-Chimi 2017; Jiravisitkul 2017;
Mercadante 2016; Ngan 2017; Schwaberger 2015). One of the
trials included in this update was not pooled with the other studies
for analysis because investigators superimposed the intervention
on chest compressions (Schmölzer 2015).
Sustained lung inflation was not better than intermittent ventila-
tion for reducing mortality - the primary outcome of this review.
We rated the quality of evidence as moderate (GRADE) for death
before discharge (limitations in study design of most included tri-
als) and as low (GRADE) for death in the delivery room (limita-
tions in study design and imprecision of estimates). When con-
sidering secondary outcomes, such as need for intubation, need
for or duration of respiratory support, bronchopulmonary dyspla-
sia, or pneumothorax, we found no benefit of SLI over intermit-
tent ventilation. The quality of evidence for secondary outcomes
was moderate (limitations in study design of most included tri-
als - GRADE), except for pneumothorax (low quality: limitations
in study design and imprecision of estimates - GRADE). Dura-
tion of mechanical ventilation was shorter in the SLI group (low
quality: limitations in study design and imprecision of estimates
- GRADE). The first version of this review reported an increased
rate of patent ductus arteriosus (PDA) in the sustained lung in-
flation group. However, this effect was not seen when the most
recent trials were added to the analysis. We identified six ongoing
trials.
Overall completeness and applicability of
evidence
To date, seven trials comparing sustained versus standard infla-
tions for initial resuscitation have enrolled 941 newborns. Avail-
able data were insufficient for assessment of clinically important
outcomes, which were identified a priori. Study authors did not
report outcomes such as duration of supplemental oxygen re-
quirement and long-term neurodevelopmental outcomes and did
not enrol term infants. We could not perform an a priori sub-
group analysis (gestational age, ventilation device, interface, du-
ration of sustained inflation) to detect differential effects because
of the paucity of included trials. Relevant questions such as the
following remain unanswered: What is the optimal duration for
an SLI? Which level of positive end-expiratory pressure (PEEP)
should follow? Which is the optimal interface/device? (McCall
2016) We were able to summarise available evidence in a compre-
hensive way, as we obtained additional information about study
design and outcome data from all included trials (El-Chimi 2017;
Jiravisitkul 2017; Lindner 2005; Lista 2015; Mercadante 2016;
Ngan 2017; Schmölzer 2015; Schwaberger 2015) and from two
excluded trials (Harling 2005; te Pas 2007). The five ongoing trials
that we identified reported important differences in choice of ges-
tational age (NCT02139800; NCT02493920; NCT02846597;
NCT02858583; NCT02887924). NCT02139800 enrols in-
fants at 23 to 26 weeks, NCT02493920 at 25 to 36 weeks,
NCT02887924 at 26 to 29 weeks, and NCT02846597 at < 33
weeks, whereas NCT02858583 enrols term and preterm infants.
These differences among study populations might prove to be im-
portant, as trials have reported that sustained inflation was more
effective in infants at 28 to 30 weeks than at < 28 or > 30 weeks
of gestation (te Pas 2007).
Quality of the evidence
According to the GRADE approach, we rated the overall quality
of evidence for clinically relevant outcomes as low tomoderate (see
Summary of findings for the main comparison). We downgraded
the overall quality of evidence for critical outcomes because of lim-
itations in study design (i.e. selection bias due to lack of allocation
concealment) and imprecision of results (few events for death in
the delivery room and wide confidence intervals for pneumotho-
rax). In addition, two trials did not report sample size calculations
(El-Chimi 2017; Schwaberger 2015), and the other three did not
achieve them (Jiravisitkul 2017; Lindner 2005; Ngan 2017). Re-
sults of smaller studies are subject to greater sampling variation,
and hence are less precise. Indeed, imprecision is reflected in the
confidence interval around the intervention effect estimate from
each study and in the weight given to the results of each study
included in the meta-analysis (Higgins 2011).
Potential biases in the review process
A major limitation of this Cochrane review is the definition of
sustained lung inflation, as trials used different pressures, which
may have impacted study results. No trials were blinded owing to
the nature of the intervention. We excluded a potentially relevant
trial (te Pas 2007) because sustained inflation was only one ele-
ment of the intervention, and it is not possible to determine the
relative contributions of various elements of this intervention to
differences observed between groups. We excluded Harling 2005
because the control group received 2 seconds of inflation (5 sec-
onds for the intervention group), whereas we defined sustained as
> 1 second. For this update, we made a post hoc decision to add a
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comparison based on the presence of chest compressions during
resuscitation.
Agreements and disagreements with other
studies or reviews
Several systematic reviews of SLI have been recently published.
Schmölzer 2014 conducted a systematic review of randomised
clinical trials comparing SLI versus intermittent positive-pressure
ventilation (IPPV) as the primary respiratory intervention during
respiratory support in preterm individuals at < 33 weeks of gesta-
tional age in the delivery room.This review included four trials, in-
cluding two that we excluded from our systematic review (Harling
2005; te Pas 2007). Schmölzer 2014 reported a significant reduc-
tion in the need for mechanical ventilation within 72 hours after
birth (typical risk ratio (RR) 0.87, 95% confidence interval (CI)
0.74 to 1.03). As in our analysis, significantly more infants treated
with SLI received treatment for PDA (RR 1.27, 95% CI 1.05 to
1.54). Results showed no differences in bronchopulmonary dys-
plasia (BPD), death at latest follow-up, or the combined outcome
of death or BPD among survivors between groups. The findings
of Schmölzer 2014 differ from the findings of this Cochrane re-
view because of differences in the definition of duration of the
intervention, and therefore in determination of included trials. A
narrative review (Foglia 2016) including five trials (Harling 2005;
Lindner 2005; Lista 2015; Mercadante 2016; te Pas 2007) con-
cluded that at present, data are insufficient to support the use of
SLI in clinical practice. An observational analytical cross-sectional
case-control study of 78 preterm infants showed that SLI resulted
in lower rates of intubation in the delivery room, lower rates of in-
vasive mechanical ventilation, and higher rates of intraventricular
haemorrhage (Grasso 2015).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Sustained lung inflation was not better than intermittent ventila-
tion for reducing mortality in the delivery room (low-quality ev-
idence - GRADE) and during hospitalisation (moderate-quality
evidence -GRADE) - primary outcomes of this review.When con-
sidering secondary outcomes, such as need for intubation, need
for or duration of respiratory support, or bronchopulmonary dys-
plasia, we found no benefit of sustained inflation over intermittent
ventilation (moderate-quality evidence - GRADE). Duration of
mechanical ventilation was shortened in the SLI group (low-qual-
ity evidence - GRADE); however, this result should be interpreted
cautiously, as it might have been influenced by study characteris-
tics other than the intervention.
Implications for research
Additional studies of SLI for infants receiving respiratory support
at birth should provide more detailed monitoring of the proce-
dure, such as measurements of lung volume and presence of ap-
noea before or during SLI. Future randomised controlled trials
should aim to enrol infants who are at higher risk of morbidity
and mortality, and should stratify participants by gestational age.
Researchers should also measure long-term neurodevelopmental
outcomes (e.g. Bayley Scales of Infant Development administered
at two years of corrected age).
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
El-Chimi 2017
Methods Prospective quasi-randomised parallel controlled trial
Setting: delivery room of Maternity Hospital, Ain Shams University, Cairo, Egypt
Conducted: April 2012 to March 2014
Participants Inclusion criteria (as specified in the protocol): gestational age 26 to 33 weeks, birth
weight > 750 grams
Exclusion criteria (as specified in the protocol): major congenital anomalies; meconium
aspiration syndrome, congenital diaphragmatic hernia, anterior abdominal wall defect,
maternal chorioamnionitis
Interventions • SLI group: PIP of 20 cmH2O for 15 seconds, using a neonatal mask and a T-
piece ventilator, followed by PEEP of 5 cmH2O. If response was not satisfactory (i.e.
breathing remained insufficient and/or heart rate was < 100 bpm and/or the infant was
cyanotic): A second 15 second SLI of 25 cmH2O for 15 seconds, followed by PEEP of
6 cmH2O. If still not satisfactory, a third SLI of 30 cmH2O for 15 seconds, followed
by PEEP of 7 cmH2O. If still not satisfactory, intubation inside DR and ventilation
(rate of 40 to 60 breaths/min, PIP of 25 to 35 cmH2O, PEEP of 7 to 8 cmH2O) until
transfer to NICU
• Control group: intermittent bag/mask inflation: rate of 40 to 60 breaths/min,
maximum PIP of 40 cmH2O for 30 seconds using a self-inflating bag with an oxygen
reservoir. After adequate circulation and breathing achieved, CPAP of 5 to 7 cmH2O
during transfer to NICU. In cases of poor response, intubation and ventilation (rate of
40 to 60 breaths/min, PIP of 25 to 35 cmH2O, PEEP of 7 to 8 cmH2O) until transfer
to NICU
Outcomes Primary outcome was either “success” (defined as no need for further ventilatory support,
need for exclusiveNCPAP, or need for intubation beyond the first 72 hours after delivery)
or “failure” (defined as need for intubation within first 72 hours of life, including DR
intubation)
Secondary outcomes were blood IL-1b and TNF-a levels, air leaks, BPD, IVH, PDA,
and NEC
Notes Study was registered at ClinicalTrials.gov (Identifier: NCT01255826)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk For randomisation, sequentially numbered
sheets were used to assign eligible infants to
resuscitation: Odd-numbered sheets indi-
cated those allocated to the SLI group, and
even-numbered to the control group
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El-Chimi 2017 (Continued)
Allocation concealment (selection bias) High risk No opaque envelopes were used (informa-
tion provided by study authors)
Blinding (performance bias and detection
bias)
All outcomes
High risk Assigned intervention could not be blinded
to the resuscitation team
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information provided
Incomplete outcome data (attrition bias)
All outcomes
High risk After enrolment (n = 202), infants referred
to other NICUs were excluded from anal-
ysis owing to failure of follow-up. At study
end, SLI group comprised 57 babies and
CBMI group comprised 55 babies
Selective reporting (reporting bias) High risk Some outcomes were specified at
https://clinicaltrials.gov/
ct2/show/NCT01255826 but were not re-
ported in the manuscript (e.g. duration of
oxygen therapy, length of NICU stay)
Other bias Low risk Appears free of other bias
Jiravisitkul 2017
Methods Prospective randomised parallel controlled trial
Setting: delivery roomofRamathibodiHospital,MahidolUniversity, Bangkok,Thailand
Conducted: November 2013 to March 2015
Participants Included: 81 preterm infants (25 to 32 weeks of gestational age) requiring positive-
pressure ventilation or continuous positive airway pressure
Exclusion criteria: major congenital anomalies, hydrops foetalis, prenatal diagnosis of
upper airway obstruction, meconium-stained amniotic fluid
Interventions • SLI group (n = 43): SLI at 25 cmH2O for 15 seconds with neonatal mask via a T-
piece resuscitator, followed by delivery of CPAP at 6 cmH2O via a face mask for 5 to
10 seconds. Cardiorespiratory status was then re-evaluated: If HR was ≥100 beats/min
and respiratory effort was improved, CPAP was continued via face mask. If HR was <
60 beats/min, PPV was initiated. If HR was 60 to 100 beats/min and/or respiratory
effort was poor, a second SLI manoeuvre similar to the first SLI manoeuvre was
initiated. If HR was < 100 beats/min or gasping/apnoea was present during the second
SLI manoeuvre, PPV was initiated and additional resuscitation steps performed. If HR
was ≥ 100 beats/min and no apnoea/gasping was present during the second SLI
manoeuvre, CPAP was performed via face mask
• Non-SLI group (n = 38): standard resuscitation alone. PPV was given via a T-
piece resuscitator with PIP of 15 to 20 cmH2O and positive end-expiratory pressure of
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Jiravisitkul 2017 (Continued)
5 cmH2O for 30 seconds. Infants were placed on CPAP at 6 cmH2O via face mask if
breathing was still laboured
All enrolled infants were resuscitated with an initial fraction of inspired oxygen (FiO2) of
0.3, which was adjusted by 0.1 every 30 seconds to achieve the target SpO2. Criteria for
intubation included 1 of the following: remaining apnoeic after PPV, HR of 30 seconds
before the start of chest compressions, or SpO2 < 80% despite CPAP via mask with FiO2
of 1.0 for 5 to 10 minutes
Infants of multiple gestations were enrolled in the same intervention group
Outcomes Primary outcomes: change in oxygen requirements, HR, and SpO2 during resuscitation;
proportion of infants on room air during first 10 minutes after birth; need for intubation
in the delivery room
Secondary outcomes: survival at discharge, duration of hospitalisation, proportion of
infants on MV within first 72 hours of life, duration of MV, duration of oxygen supple-
mentation, need for surfactant, need for postnatal steroids, pneumothorax within first 48
hours after NICU admission, moderate to severe BPD as defined by Jobe and Bancalari,
Apgar score at 5 minutes, PDA and need for surgical closure, grade 3 to 4 IVH, cystic
periventricular leukomalacia, stage > 2 ROP, ROP requiring treatment
Notes Study was registered in the Thai Clinical Trials Registry (TCTR20140418001)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Block of 4 randomisation stratified by GA:
25 to 28 weeks and 29 to 32 weeks. Ran-
dom sequence was generated by computer
random number generator (information
provided by study authors)
Allocation concealment (selection bias) Low risk Sequence numbers were kept in opaque
sealed envelopes that were opened just be-
fore birth in the delivery room by a person
not involved in resuscitation of infants
Blinding (performance bias and detection
bias)
All outcomes
High risk Assigned intervention could not be blinded
to the resuscitation team
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information provided
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear why 43 infants in SLI group and
38 in control group
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Jiravisitkul 2017 (Continued)
Selective reporting (reporting bias) Unclear risk According to the Thai Clinical Trials Reg-
istry (TCTR20140418001), the only pri-
mary outcome was intubation in DR; only
a key secondary outcome was specified:
BPD
Other bias Unclear risk Planned sample size: 40 infants in each
group; however, only 38 in control group
Lindner 2005
Methods Prospective randomised parallel controlled trial
Setting: Delivery Room, Ulm, Germany
Conducted: August 1999 to February 2002
Participants Inclusion criteria: newly born infants at 25 to 28 weeks of gestation inclusive
Exclusion criteria: severe malformations, oligo-anhydramnios before 20 weeks of gesta-
tion, foeto-foetal transfusion syndrome
A total of 61 infants were enrolled (31 in sustained inflation group and 30 in control
group)
Interventions • SLI group: PIP 20 cmH2O for 15 seconds. Infants who did not respond
satisfactorily (persistent poor or laboured respiratory effort, bradycardia or cyanosis,
and low oxygen saturation (SpO2)): up to 2 additional inflations of 15 seconds at
higher inflating pressures (25 and 30 cmH2O). Infants whose response remained
unsatisfactory were intubated and mechanically ventilated
• Control group: NIMV (PIP 20 cmH2O, PEEP 4 to 6 cmH2O; inflation time 0.5
seconds; inflation rate 60/min) for 30 seconds before the start of NCPAP at 4 to 6
cmH2O
Infants received support from a mechanical ventilator via a nasopharyngeal tube
Infants in both groups who had apnoea on NCPAP could be treated with NIMV (PIP
20 cmH2O; inflation time 0.3 seconds; inflation rate 60/min) for up to 4 minutes
Treatment was deemed to have failed if infants had shown persistently poor respiratory
effort, bradycardia, or cyanosis/low SpO2 in the delivery room; or if criteria combining
clinical assessments of respiratory distress and evidence of impaired oxygenation, im-
paired ventilation (high CO2), or apnoea were met within 48 hours of birth
Outcomes Primary outcome: rate of infants reaching criteria for intubation and mechanical venti-
lation at < 48 hours of life
Secondary outcomes: mortality, Apgar score, endotracheal intubation, surfactant admin-
istration, duration of respiratory support, chronic lung disease, air leak, intraventricular
haemorrhage, cystic periventricular leukomalacia, retinopathy of prematurity, PDA
Notes Trial was stopped before target sample was recruited owing to slow enrolment. Clinical
outcomes were reported for all randomised infants
Risk of bias
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Lindner 2005 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Block randomised, stratified for gestational
age (25 to 26 weeks, 27 to 28 weeks)
Allocation concealment (selection bias) Low risk Sealed opaque envelopes used
Blinding (performance bias and detection
bias)
All outcomes
High risk Assigned intervention could not be blinded
to the resuscitation team
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information provided
Incomplete outcome data (attrition bias)
All outcomes
Low risk All infants accounted for
Selective reporting (reporting bias) Low risk All reported outcomes provided with com-
plete results
Other bias High risk Trial lacks power because only 61 infants
were enrolled (instead of 110)
Lista 2015
Methods Multi-centre prospective randomised parallel controlled trial
Setting: Delivery Room, Italy
Conducted: October 2011 to January 2013
Infants were assigned immediately after birth before the first breath to receive SLI ma-
noeuvres and NCPAP or NCPAP alone in a 1:1 ratio in permuted blocks of variable size.
Randomisation was stratified according to centre and gestational age (25 or 26 weeks
and 27 or 28 weeks). Group assignment was contained in sequentially numbered, sealed,
opaque envelopes that were prepared by an independent statistician. The trial was not
blinded
Participants Newly born infants at 25 to 28 weeks of gestation inclusive without major congenital
malformations (i.e. congenital heart, cerebral, lung, abdominal malformations), foetal
hydrops, and lack of parental consent. A total of 294 infants were enrolled (150 in the
sustained lung inflation group and 144 in the control group)
Interventions • SLI group: PIP 25 cmH2O for 15 seconds, followed by delivery of 5 cmH2O
CPAP, via a neonatal mask and a T-piece ventilator. Participants were observed for the
next 6 to 10 seconds for evaluation of cardiorespiratory function. If respiratory failure
persisted (i.e. apnoea, gasping) or heart rate was 60 and 100 beats/min despite CPAP,
the SLI manoeuvre (again 25 cmH2O for 15 seconds) was repeated. If heart rate
remained 60 and 100 beats/min after the second SLI manoeuvre, the infant was
resuscitated according to AAP guidelines
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Lista 2015 (Continued)
• Control group: NCPAP at 5 cmH2O with assistance according to AAP guidelines
Infants in both groups who were not intubated in the delivery room were transferred to
the NICU on NCPAP at 5 cmH2O with a fraction of inspired oxygen (FiO2) of 0.21
to 0.40 (in agreement with local protocols)
Outcomes Primary outcome: rate of infants reaching mechanical ventilation within the first 72
hours of life
Secondary outcomes: MV in the first 3 hours of life, highest FiO2, duration of NCPAP,
need for and duration of bi-level NCPAP, nasal IMV, conventional or high-frequency
ventilation, duration of hospitalisation, need for and number of doses of surfactant,
occurrence of RDS, BPD, and mortality
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Block randomised (1:1 ratio), stratified for
gestational age (25 to 26 weeks, and 27 to
28 weeks)
Allocation concealment (selection bias) Low risk Group assignment was contained in se-
quentially numbered, automatically gener-
ated, sealed, opaque envelopes that were
prepared by an independent statistician and
distributed to participating centres
Blinding (performance bias and detection
bias)
All outcomes
High risk Assigned intervention could not be blinded
to the resuscitation team
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Staff performing the study also cared for
infants later on. However, the decision to
startMVwas made by clinicians other than
investigators involved in the study accord-
ing to specific guidelines, and researchers
assessing study endpoints were blinded to
the nature of study treatments
Incomplete outcome data (attrition bias)
All outcomes
Low risk Only 0.7% (control group) and 1.3% (SLI
group) of participants were lost
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk Appears free of other bias
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Mercadante 2016
Methods Prospective randomised parallel controlled trial
Setting: Delivery Room, Neonatal Intensive Care Unit (NICU) in Milan, Italy
Conducted: September 2013 to June 2014
Participants Inclusion criteria: inborn infants with a gestational age of 34 to 36 weeks after parental
consent is obtained
Exclusion criteria: major congenital anomalies
Interventions • SLI group: PIP 25 cmH2O for 15 seconds in the delivery room, followed by
PEEP of 5 cmH2O. In case of persistent hearth failure (HR < 100 bpm), a second SLI
manoeuvre will be repeated
• Control group: CPAP 5 cmH2O with mask
In both groups, mask and T-piece system were used
Outcomes Primary outcome: need for respiratory support
Secondary outcomes: air leak syndromes, NICU admission, NICU admission for respi-
ratory disease, length of stay, exclusive breastfeeding at discharge
Notes Sample size described
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information provided
Allocation concealment (selection bias) Low risk Sealed opaque envelopes
Blinding (performance bias and detection
bias)
All outcomes
High risk Assigned intervention could not be blinded
to the resuscitation team
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk The decision to start respiratory support
was made by clinicians other than investi-
gators involved in the study according to
specific guidelines, and researchers assess-
ing study endpoints were blinded to the na-
ture of study treatments
Incomplete outcome data (attrition bias)
All outcomes
Low risk All outcomes accounted for
Selective reporting (reporting bias) High risk We could not ascertain whether deviations
from the original protocol were evident in
the final publication
Other bias Low risk
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Ngan 2017
Methods Prospective randomised parallel controlled trial
Setting: Delivery Room, Neonatal Intensive Care Unit (NICU), Royal Alexandra Hos-
pital (RAH), Edmonton, Canada
Conducted: June 2013 to August 2014
Participants Inclusion criteria: infants between 23+0 and 32+6 weeks of gestation who require respi-
ratory support for resuscitation in the delivery room
Exclusion criteria: congenital abnormality or condition that might have an adverse effect
on breathing or ventilation; absence of parents’ consent for inclusion in the study
Interventions • SLI group: 2 PIPs of 24 cmH2O. Duration of first SLI was 20 seconds. Duration
of second SLI was 20 or 10 seconds if ECO2 value was < or > 20 mmHg, respectively.
After SLIs, CPAP if breathing spontaneously or, if found to have apnoea or laboured
breathing, mask IPPV at a rate of 40 to 60 bpm
• Control group: mask IPPV, ventilation rate of 40 to 60 inflations/min until
spontaneous breathing, at which time CPAP will be provided
Outcomes Primary outcome: BPD (need for respiratory support or supplemental oxygen at cor-
rected gestational age of 36 weeks)
Secondary outcomes: rate of endotracheal intubation in the DR or the NICU, duration
of MV and non-invasive ventilation, neonatal death, air leak, PDA (medical or surgical),
NEC, ROP, periventricular leukomalacia, abnormal cranial ultrasound (including IVH,
parenchymal injury, and ventriculomegaly), surfactant administration, postnatal steroids,
respiratory support or oxygen requirements at 28 days, neonatal death before discharge
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Com-
puter-generated randomisation scheme (1:
1 ratio). Randomisation stratified accord-
ing to gestational age (to infants 23+0 to 27
+6 and 28+0 to 32+6 weeks). Twins and/or
triplets were randomised as individuals
Allocation concealment (selection bias) Unclear risk A sequentially numbered, brown, sealed
envelope contained a folded card box with
treatment allocation opened by the clinical
team immediately before delivery
Timing of randomisation resulted in many
post-randomisation exclusionswith the po-
tential of inadequate allocation conceal-
ment, as more post-randomisation exclu-
sions occurred in the SLI group than in the
control group
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Ngan 2017 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
High risk Assigned intervention could not be blinded
to the resuscitation team
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk After admission into theNICU, the clinical
teamwas not made aware of treatment allo-
cation. In addition, both data collector and
outcome assessor were unaware of group
allocation. The research team was not in-
volved in clinical care of the infants
Incomplete outcome data (attrition bias)
All outcomes
High risk Post-randomisation exclusion (27%) re-
sulted in fewer included infants in the SLI
group; this discrepancy might have yielded
different results
Selective reporting (reporting bias) Low risk Protocol was registered at Clinicaltrials.gov
(NCT01739114)
Other bias Unclear risk Planned sample size of 93 infants in each
group was not achieved. Moreover, inci-
dence of the primary outcome in the con-
trol group was lower than assumed for the
sample size calculation, further underpow-
ering the trial to detect the desired effect
size
Schmölzer 2015
Methods Prospective randomised parallel controlled trial
Pilot (5 infants randomised to each group)
Setting: Royal Alexandra Hospital, Edmonton, Alberta, Canada
Participants Inclusion criteria: inborn infants between 23+0 and 32+6 weeks of postmenstrual age
who required chest compressions in the delivery room
Exclusion criteria: congenital abnormality or condition that might have an adverse effect
on breathing or ventilation (e.g. congenital pulmonary or airway anomalies, congenital
diaphragmatic hernia, congenital heart disease requiring intervention in neonatal period)
Interventions • SLI group: SLI of 20 + 20 seconds, plus uninterrupted chest compression at a rate
of 90/min
• Control group: 3:1 compression:ventilation (C:V) ratio according to current
resuscitation guidelines
Default settings for airway pressures: PIP of 24 cmH2O and PEEP of 6 cmH2O
Outcomes Primary outcome: return of spontaneous circulation
Secondary outcomes (we obtained the following information directly from trial authors)
: all mortality before discharge from hospital, delivery room interventions (rate of in-
37Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Schmölzer 2015 (Continued)
tubation, use of epinephrine), mechanical ventilation, use of inotropic agents, NEC,
moderate to severe BPD, ROP, brain injury as indicated by abnormal neuroimaging
Notes Available as an abstract only (Canadian Paediatric Society 92nd Annual Conference)
Trial was registered at ClinicalTrials.gov: NCT02083705
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Low risk Although not reported in the abstract,
we obtained the following information di-
rectly from trial authors: A sequentially
numbered, brown, sealed envelope con-
tained a folded card box with treatment al-
location
Blinding (performance bias and detection
bias)
All outcomes
High risk Assigned intervention could not be blinded
to the resuscitation team
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Although not reported in the abstract,
we obtained the following information di-
rectly from trial authors: Both data collec-
tor and outcome assessor were unaware of
group allocation
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not reported
Selective reporting (reporting bias) High risk Trial was registered at ClinicalTrials.gov:
NCT02083705. However, secondary out-
comes were not specified
Other bias Low risk Appears free of other bias
Schwaberger 2015
Methods Prospective randomised parallel controlled trial
Setting: Delivery Room, Graz, Austria
Conducted: April 2012 to December 2013
Participants Inclusion criteria: preterm infants (28 weeks 0 days to 33 weeks 6 days) delivered by
elective Caesarean section with HR < 100 or irregular breathing and/or pronounced
signs of respiratory distress (grunting, tachypnoea, and increased work of breathing)
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Schwaberger 2015 (Continued)
Exclusion criteria: major congenital malformations, inherited disorders of metabolism
andnecessity of primary intubationwithinfirst 15minutes after birth. In cases ofmultiple
birth, only 1 of the infants was included
Interventions Cord clamping within 30 seconds after delivery. Respiratory support with a T-piece
system in the delivery room
• SLI group: PIP 30 cmH2O for 15 seconds, with mask, to be repeated once or
twice with HR remaining below 100 bpm. Infants with HR > 100 bpm were
supported by PPV at 30 cmH2O PIP or CPAP at a PEEP level of 5 cmH2O depending
on respiratory rate
• Control group: Respiratory support was provided according to AHA guidelines.
CPAP (5 cmH2O PEEP) was applied in infants with respiratory rate > 30 breaths per
minute and signs of respiratory distress. Insufficient breathing efforts (HR < 100 bpm,
respiratory rate < 30 breaths per minute or irregular breathing) indicated PPV at 30
cmH2O PIP via face mask
Initial fraction of inspired oxygen (FiO2) of 0.3 was adapted to achieve defined oxygen
saturation targets (3‘: > 60%; 5‘: > 75%; 10‘: > 85%)
Outcomes Primary outcome: changes in cerebral blood volume and cerebral tissue oxygenation
index during immediate postnatal transition
Secondary outcomes: SpO2, HR, VT, face mask leak, FiO2 within first 15 minutes after
birth
Notes Trial was registered at the German Clinical Trials Register (DRKS00005161) in July
2013, after study initiation (April 2012)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated blocked randomisa-
tion, 1:1 ratio, with a block size of 8 (www.
randomizer.at)
Allocation concealment (selection bias) Low risk Sealed envelopes were used. We obtained
the following information directly from
trial authors: Envelopes were opaque
Blinding (performance bias and detection
bias)
All outcomes
High risk Assigned intervention could not be blinded
to the resuscitation team
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Cerebral ultrasound pictures were evalu-
ated by a neonatologist blinded to partici-
pants. No informationwas provided for the
other outcomes
Incomplete outcome data (attrition bias)
All outcomes
Low risk All outcomes accounted for
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Schwaberger 2015 (Continued)
Selective reporting (reporting bias) Low risk Protocol for this trial is available as support-
ing information. Reporting of the study
conforms to Consolidated Standards of Re-
porting Trials (CONSORT) 2010 state-
ment
Other bias Low risk Appears free of other bias.
AAP: American Academy of Pediatrics
AHA: American Heart Association
BPD: bronchopulmonary dysplasia
C:V: compression:ventilation
CBMI: conventional bag/mask inflation
CPAP: continuous positive airway pressure
DR: delivery room
ECO2: enzymatic carbonate (measure of carbon dioxide in the blood)
FiO2: fraction of inspired oxygen
HR: heart rate
IL-1b: interleukin-1beta
IMV: intermittent mandatory ventilation
IPPV: intermittent positive pressure ventilation
IVH: intraventricular haemorrhage
MV: mandatory ventilation
NCPAP: nasal continuous positive airway pressure
NEC: necrotising enterocolitis
NICU: neonatal intensive care unit
NIMV: nasal intermittent mandatory ventilation
PDA: patent ductus arteriosus
PEEP: positive end-expiratory pressure
PIP: peak inspiratory pressure
PPV: positive pressure ventilation
RDS: respiratory distress syndrome
ROP: retinopathy of prematurity
SLI: sustained lung inflation
SpO2: blood oxygen saturation level
TNF-a: tumour necrosis factor-alpha
VT: ventricular tachycardia
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Bouziri 2011 Not a clinical trial. Does not investigate sustained lung inflation
Harling 2005 Control group consisted of inflation for 2 seconds (5 seconds for intervention): As we defined sustained if > 1 second,
this trial could not be included
Infants in the SLI group were born more preterm and had lower median birth weight than those in the conventional
group, although the P value was not provided. Median birth weight (range) was 885 (518 to 1460) grams in the SLI
group and 1095 (560 to 1562) grams in the conventional group. Median gestational age (range) was 27 (23 to 30)
weeks in the SLI group and 28 (23 to 31) weeks in the conventional group
te Pas 2007 This RCT enrolled newly born infants born at < 33 weeks of gestation free of known major congenital anomalies
with respiratory distress
Infants were randomised to inflation of 10 seconds at 20 cmH2O with a T-piece via a nasal tube, or to intermittent
PPV with a self-inflating bag via a face mask. Infants randomised to the T-piece received inflation for 10 seconds
at 20 cmH2O followed by NCPAP at 5 to 6 cmH2O. If the infant’s clinical response was unsatisfactory, another
inflation of 10 seconds at 25 cmH2O andNIMV (PIP 20 to 25 cmH2O, inflation rate 60 perminute) could be given.
If the infants’ condition improved (satisfactory heart rate and colour) but they had irregular breathing, they could
receive NIMV for several minutes. Infants who were judged to have inadequate breathing, remain bradycardic, or
remain cyanosed in the delivery room after these interventions were intubated and mechanically ventilated. Infants
randomised to the self-inflating bag received initial inflations of 30 to 40 cmH2O, followed by inflations not > 20
cmH2O (inflation time was not specified or recorded) for 30 seconds. Infants judged to have inadequate breathing,
remain bradycardic, or remain cyanosed in the delivery room after this intervention were intubated and mechanically
ventilated. Infants in the sustained lung inflation group who were not intubated were transferred to the neonatal
intensive care unit (NICU) onNCPAP at 5 to 6 cmH2O; non-intubated infants in the control group were transferred
to the NICU with supplemental oxygen and were monitored with pulse oximetry
The intervention in this trial was multi-faceted. In addition to a sustained inflation, many other aspects of respiratory
care provided at birth differed between groups (ventilation device used; interface used; whether PEEP was used;
whether NIMV was used; time allowed for stabilisation before intubation was considered; time of starting NCPAP)
. It is not possible to determine the relative contribution (if any) of each element of this intervention to differences
in outcomes observed between groups
NCPAP: nasal continuous positive airway pressure
NICU: neonatal intensive care unit
NIMV: nasal intermittent mandatory ventilation
PEEP: positive end-expiratory pressure
PIP: peak inspiratory pressure
PPV: positive pressure ventilation
RCT: randomised controlled trial
SLI: sustained lung inflation
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Characteristics of ongoing studies [ordered by study ID]
NCT02139800
Trial name or title Sustained aeration of infant lungs trial (SAIL)
Methods Two-arm randomised controlled multi-centre clinical trial
Participants Infants of 23 to 26 weeks of gestational age requiring respiratory support at birth. Sample size: 600 infants
Inclusion criteria: gestational age at least 23 weeks but less than 27 completed weeks by best obstetrical
estimate; requiring resuscitation/respiratory intervention at birth
Exclusion criteria: considered non-viable by attending neonatologist; refusal of antenatal informed consent;
known major anomalies, pulmonary hypoplasia. Mothers unable to provide consent for medical care and who
do not have a surrogate guardian will not be approached for consent
Interventions SLI group: sustained inflation in the delivery room. The first sustained inflation will use inflation pressure of
20 cmH2O for 15 seconds
Control group: CPAP of 5 to 7 cmH2O in the delivery room
Outcomes Primary outcome: combined endpoint of death or BPD at 36 weeks of gestational age
Secondary outcomes: oxygen profile over first 24 hours; oxygen profile with highest fraction of inspired oxygen
(FiO2) level up to 48 hours; highest FiO2 level recorded during first 48 hours; heart rate in the delivery room
(DR); detailed status on departure fromDR; type of respiratory support (CPAP, PPV) and FiO2 on departure
fromDR; use of inotropic agents on arrival in NICU; circulatory support; need for intubation in DR or by 24
hours of age; pressure-volume characteristics in DR; chest x-ray reports showing pneumothorax or new chest
drains in first 48 hours of life; duration of any chest drain in situ; head ultrasound and/or MRI findings of
intraventricular haemorrhage; chest x-ray betweendays 7 and 10; death or need for positive pressure ventilation
at 7 days; highest FiO2 and area under the FiO2 curve for first week of life; pneumothorax and pulmonary
interstitial emphysema (PIE); survival to discharge home without BPD, retinopathy of prematurity (grades
3 and 4), or significant brain abnormalities on head ultrasound; duration of respiratory support (ventilation,
CPAP, supplemental oxygen); death in hospital; retinopathy of prematurity (ROP) stage 3 or greater requiring
treatment; use of postnatal steroids for treatment of BPD; length of hospital stay; neurodevelopmental and
respiratory outcome at 22 to 26 months of corrected gestational age
Starting date August 2014.
Contact information Haresh Kirpalani, BM, MSc; kirpalanih@email.chop.edu
Sarah J Ratcliffe, PhD; sratclif@upenn.edu.
Notes Estimated enrolment: 600
Estimated primary completion date: December 2017
NCT02493920
Trial name or title Evaluation of pulmonary mechanics in preterm infant treated with sustained lung inflation at birth
Methods Prospective randomised parallel controlled trial
Participants Preterm infants at 25 to 36 weeks
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NCT02493920 (Continued)
Interventions SLI group: PIP of 25 cmH2O for 15 seconds followed by PEEP of 5 cmH2O; second SLI in case of poor
response
Control group: CPAP of 5 cmH2O with mask
Outcomes Primary outcomes: change in reactance values measured by forced oscillation technique
Secondary outcomes: need for intubation within first 72 hours of life; duration of respiratory support;
death in hospital; number of surfactant doses; ROP stage 3 or greater requiring treatment; PDA requiring
treatment; BPD; IVH
Starting date July 2015
Contact information Mariarosa Colnaghi, MD; mariarosa.colnaghi@mangiagalli.it
Domenica Mercadante, MD; domenica.mrc@hotmail.it
Notes Estimated enrolment: 48
Estimated primary completion date: December 2015
NCT02846597
Trial name or title Sustained lung inflation at birth for preterm infants at risk of respiratory distress syndrome: the proper pressure
and duration: prospective randomised study
Methods Prospective randomised parallel controlled trial
Participants Preterm infants ≤ 32 weeks of gestation with respiratory distress syndrome at birth
Interventions Five arms: evaluating 2 different pressures - 20 and 15 cmH2O, and for 2 different durations - 10 and 20
seconds, during application of sustained lung inflation in resuscitation of preterm infants with respiratory
distress in the delivery room, plus a control group without any SLI (CPAP 5 cmH2O)
Outcomes Primary outcome: need for endotracheal intubation in the delivery room
Secondary outcomes: need for mechanical ventilation; need for surfactant; neonatal mortality; death before
hospital discharge; BPD; IVH; ROP; NEC; length of NICU and hospital stay; air leak syndrome
Starting date March 2013
Contact information Nehad Nasef, Associate Professor
Mansoura University Children Hospital, El Dakahlya, Egypt
Notes Estimated enrolment: 100
Estimated primary completion date: October 2016 (for primary outcome)
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NCT02858583
Trial name or title SURV1VE-Trial - Sustained inflation and chest compression versus 3:1 chest compression to ventilation ratio
during cardiopulmonary resuscitation of asphyxiated newborns: a randomised controlled trial
Methods Prospective randomised parallel controlled trial
Participants Infants (term or preterm infants) requiring chest compressions in the delivery room
Interventions SLI group: PIP of 25 to 30 cmH2O for 45 seconds while receiving chest compression. This will be followed
by PEEP of 5 to 8 cmH2O. If heart rate < 60/min, continue with chest compression + SLI for another 45
seconds. If heart rate remains < 60/min, continue with CC + SI
Control group: chest compression at a rate of 90/min and 30 ventilations/min in a 3:1 C:V ratio
Outcomes Primary outcomes: return of spontaneous circulation; duration of chest compression heart rate is > 60/min
for 15 seconds
Starting date January 2017
Contact information Georg Schmolzer, MD, PhD; georg.schmoelzer@me.com
University of Alberta
Notes Estimated enrolment: 118
Estimated primary completion date: December 2018
NCT02887924
Trial name or title The effect of sustained lung inflation maneuver applied through nasal prong on early and late respiratory
morbidities in preterm infants
Methods Prospective randomised parallel controlled trial
Participants Preterm infants of 26 weeks 0 days and 29 weeks 6 days
Interventions SLI group: PIP 25 cmH2O for 15 seconds with T-piece and bi-nasal prongs; second SLI in case of poor
response
Control group: CPAP
Outcomes Primary outcome: surfactant need, intubation and mechanical ventilation needs within first 72 hours of life
Secondary outcomes: heart rate, fractional inspiratory oxygen, CPAP pressure and oxygen saturation within
first 72 hours of life in preterm infants; total non-invasive, invasive respiratory support time; BPD; PDA;
IVH, NEC; ROP; feeding intolerance, reaching birth weight; transition to full oral feeding time
Starting date August 2016
Contact information Zekai Tahir Burak Women’s Health Research and Education Hospital, Ankara, Turkey
Notes Estimated enrolment: 250
Estimated primary completion date: September 2017
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BPD: bronchopulmonary dysplasia
CC: chest compression
C:V: compression: ventilation
CPAP: continuous positive airway pressure
DR: delivery room
FiO2: fraction of inspired oxygen
IVH: intraventricular haemorrhage
NICU: neonatal intensive care unit
PEEP: positive end-expiratory pressure
PIE: pulmonary interstitial emphysema
PIP: peak inspiratory pressure
PPV: positive pressure ventilation
ROP: retinopathy of prematurity
SI: sustained inflation
SLI: sustained lung inflation
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D A T A A N D A N A L Y S E S
Comparison 1. Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with
no chest compressions
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Death 7 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Death in the delivery
room
5 479 Risk Ratio (M-H, Fixed, 95% CI) 2.66 [0.11, 63.40]
1.2 Death before discharge 7 932 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.67, 1.51]
2 Apgar at 1 minute 5 529 Mean Difference (IV, Fixed, 95% CI) -0.08 [-0.26, 0.09]
3 Apgar at 5 minutes 6 641 Mean Difference (IV, Fixed, 95% CI) -0.02 [-0.13, 0.08]
4 Endotracheal intubation 7 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
4.1 Endotracheal intubation
in the delivery room
5 601 Risk Ratio (M-H, Fixed, 95% CI) 0.86 [0.62, 1.19]
4.2 Endotracheal intubation
within 24 hours
2 225 Risk Ratio (M-H, Fixed, 95% CI) 1.4 [0.53, 3.68]
4.3 Endotracheal intubation
by 72 hours of age
5 811 Risk Ratio (M-H, Fixed, 95% CI) 0.93 [0.79, 1.09]
5 Surfactant administration 7 1267 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.89, 1.15]
5.1 Surfactant given in the
delivery room
3 335 Risk Ratio (M-H, Fixed, 95% CI) 1.43 [0.82, 2.49]
5.2 Surfactant given at any
time
7 932 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.86, 1.10]
6 Need for mechanical ventilation 3 484 Risk Ratio (M-H, Fixed, 95% CI) 0.87 [0.74, 1.03]
7 Duration of NCPAP 3 355 Mean Difference (IV, Fixed, 95% CI) 0.26 [-0.19, 0.72]
8 Duration of mechanical
ventilation
5 524 Mean Difference (IV, Fixed, 95% CI) -5.37 [-6.31, -4.43]
9 Duration of respiratory support
(NCPAP + MV)
2 243 Mean Difference (IV, Fixed, 95% CI) 0.69 [0.23, 1.16]
10 Duration of supplemental
oxygen requirement
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
11 Chronic lung disease 6 903 Risk Ratio (M-H, Fixed, 95% CI) 0.93 [0.77, 1.13]
11.1 BPD any grade 2 220 Risk Ratio (M-H, Fixed, 95% CI) 0.90 [0.69, 1.19]
11.2 Moderate to severe BPD 5 683 Risk Ratio (M-H, Fixed, 95% CI) 0.95 [0.74, 1.22]
12 Pneumothorax 7 932 Risk Ratio (M-H, Fixed, 95% CI) 1.40 [0.76, 2.61]
12.1 During first 48 hours 1 81 Risk Ratio (M-H, Fixed, 95% CI) 0.88 [0.06, 13.65]
12.2 At any time 6 851 Risk Ratio (M-H, Fixed, 95% CI) 1.44 [0.76, 2.72]
13 Cranial ultrasound
abnormalities
6 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
13.1 Intraventricular
haemorrhage grade 3-4
5 635 Risk Ratio (M-H, Fixed, 95% CI) 0.89 [0.58, 1.37]
13.2 IVH any grade 2 152 Risk Ratio (M-H, Fixed, 95% CI) 0.82 [0.40, 1.69]
13.3 Cystic periventricular
leukomalacia
5 635 Risk Ratio (M-H, Fixed, 95% CI) 0.59 [0.24, 1.44]
14 Retinopathy of prematurity
(ROP) stage ≥ 3
5 632 Risk Ratio (M-H, Fixed, 95% CI) 0.69 [0.44, 1.10]
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15 Patent ductus arteriosus (PDA) 6 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
15.1 PDA - pharmacological
treatment
6 745 Risk Ratio (M-H, Fixed, 95% CI) 1.08 [0.90, 1.30]
15.2 PDA - surgical closure 3 412 Risk Ratio (M-H, Fixed, 95% CI) 0.73 [0.27, 1.99]
Comparison 2. Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with
chest compressions
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Death 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 Death before discharge 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Endotracheal intubation 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 Endotracheal intubation
in the delivery room
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Surfactant administration 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
3.1 Surfactant given in the
delivery room
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Chronic lung disease 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
4.1 Moderate to severe BPD 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Pneumothorax 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
5.1 At any time 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Cranial ultrasound abnormalities 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
6.1 Intraventricular
haemorrhage grade 3 to 4
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.2 IVH any grade 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Retinopathy of prematurity
(ROP) stage ≥ 3
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
8 Patent ductus arteriosus (PDA) 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
8.1 PDA - pharmacological
treatment
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Analysis 1.1. Comparison 1 Use of initial sustained inflation vs standard inflations in newborns receiving
resuscitation with no chest compressions, Outcome 1 Death.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with no chest compressions
Outcome: 1 Death
Study or subgroup SLI control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Death in the delivery room
El-Chimi 2017 0/57 0/55 Not estimable
Lindner 2005 0/31 0/30 Not estimable
Mercadante 2016 0/93 0/92 Not estimable
Schwaberger 2015 0/20 0/20 Not estimable
Jiravisitkul 2017 1/43 0/38 100.0 % 2.66 [ 0.11, 63.40 ]
Subtotal (95% CI) 244 235 100.0 % 2.66 [ 0.11, 63.40 ]
Total events: 1 (SLI), 0 (control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.60 (P = 0.55)
2 Death before discharge
Schwaberger 2015 0/20 0/20 Not estimable
Mercadante 2016 0/93 0/92 Not estimable
El-Chimi 2017 12/57 19/55 49.8 % 0.61 [ 0.33, 1.13 ]
Jiravisitkul 2017 2/43 2/38 5.5 % 0.88 [ 0.13, 5.97 ]
Ngan 2017 5/76 5/86 12.1 % 1.13 [ 0.34, 3.76 ]
Lista 2015 17/148 12/143 31.4 % 1.37 [ 0.68, 2.76 ]
Lindner 2005 3/31 0/30 1.3 % 6.78 [ 0.37, 125.95 ]
Subtotal (95% CI) 468 464 100.0 % 1.01 [ 0.67, 1.51 ]
Total events: 39 (SLI), 38 (control)
Heterogeneity: Chi2 = 4.94, df = 4 (P = 0.29); I2 =19%
Test for overall effect: Z = 0.03 (P = 0.97)
0.01 0.1 1 10 100
Favours SLI Favours control
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Analysis 1.2. Comparison 1 Use of initial sustained inflation vs standard inflations in newborns receiving
resuscitation with no chest compressions, Outcome 2 Apgar at 1 minute.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with no chest compressions
Outcome: 2 Apgar at 1 minute
Study or subgroup SLI control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Jiravisitkul 2017 43 4.77 (2.59) 38 4.35 (2.76) 2.3 % 0.42 [ -0.75, 1.59 ]
Lindner 2005 31 4.2 (1.9) 30 3.8 (1.9) 3.4 % 0.40 [ -0.55, 1.35 ]
Mercadante 2016 93 8.4 (0.67) 92 8.5 (0.73) 76.6 % -0.10 [ -0.30, 0.10 ]
Ngan 2017 76 4 (2) 86 4 (2) 8.2 % 0.0 [ -0.62, 0.62 ]
Schwaberger 2015 20 7.6 (1.14) 20 7.9 (0.64) 9.5 % -0.30 [ -0.87, 0.27 ]
Total (95% CI) 263 266 100.0 % -0.08 [ -0.26, 0.09 ]
Heterogeneity: Chi2 = 2.34, df = 4 (P = 0.67); I2 =0.0%
Test for overall effect: Z = 0.91 (P = 0.36)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
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Analysis 1.3. Comparison 1 Use of initial sustained inflation vs standard inflations in newborns receiving
resuscitation with no chest compressions, Outcome 3 Apgar at 5 minutes.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with no chest compressions
Outcome: 3 Apgar at 5 minutes
Study or subgroup Sustained inflations Standard inflations
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
El-Chimi 2017 57 7.61 (0.65) 55 7.24 (0.86) 13.8 % 0.37 [ 0.09, 0.65 ]
Jiravisitkul 2017 43 7.36 (2.1) 38 7.1 (2.34) 1.2 % 0.26 [ -0.71, 1.23 ]
Lindner 2005 31 8 (2) 30 8 (2) 1.1 % 0.0 [ -1.00, 1.00 ]
Mercadante 2016 93 9.4 (0.43) 92 9.5 (0.44) 70.1 % -0.10 [ -0.23, 0.03 ]
Ngan 2017 76 7 (1) 86 7 (2) 4.8 % 0.0 [ -0.48, 0.48 ]
Schwaberger 2015 20 8.7 (0.47) 20 8.75 (0.64) 9.1 % -0.05 [ -0.40, 0.30 ]
Total (95% CI) 320 321 100.0 % -0.02 [ -0.13, 0.08 ]
Heterogeneity: Chi2 = 9.21, df = 5 (P = 0.10); I2 =46%
Test for overall effect: Z = 0.39 (P = 0.70)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
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Analysis 1.4. Comparison 1 Use of initial sustained inflation vs standard inflations in newborns receiving
resuscitation with no chest compressions, Outcome 4 Endotracheal intubation.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with no chest compressions
Outcome: 4 Endotracheal intubation
Study or subgroup Favours SLI Standard inflations Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Endotracheal intubation in the delivery room
El-Chimi 2017 3/57 13/55 22.9 % 0.22 [ 0.07, 0.74 ]
Jiravisitkul 2017 11/43 14/38 25.7 % 0.69 [ 0.36, 1.34 ]
Lindner 2005 10/31 7/30 12.3 % 1.38 [ 0.61, 3.16 ]
Mercadante 2016 0/93 0/92 Not estimable
Ngan 2017 25/76 24/86 39.0 % 1.18 [ 0.74, 1.88 ]
Subtotal (95% CI) 300 301 100.0 % 0.86 [ 0.62, 1.19 ]
Total events: 49 (Favours SLI), 58 (Standard inflations)
Heterogeneity: Chi2 = 8.30, df = 3 (P = 0.04); I2 =64%
Test for overall effect: Z = 0.91 (P = 0.36)
2 Endotracheal intubation within 24 hours
Mercadante 2016 0/93 0/92 Not estimable
Schwaberger 2015 7/20 5/20 100.0 % 1.40 [ 0.53, 3.68 ]
Subtotal (95% CI) 113 112 100.0 % 1.40 [ 0.53, 3.68 ]
Total events: 7 (Favours SLI), 5 (Standard inflations)
Heterogeneity: not applicable
Test for overall effect: Z = 0.68 (P = 0.49)
3 Endotracheal intubation by 72 hours of age
El-Chimi 2017 11/57 12/55 8.0 % 0.88 [ 0.43, 1.83 ]
Lindner 2005 19/31 18/30 12.0 % 1.02 [ 0.68, 1.53 ]
Lista 2015 79/148 93/143 62.1 % 0.82 [ 0.68, 1.00 ]
Mercadante 2016 2/93 1/92 0.7 % 1.98 [ 0.18, 21.44 ]
Ngan 2017 30/76 28/86 17.2 % 1.21 [ 0.80, 1.83 ]
Subtotal (95% CI) 405 406 100.0 % 0.93 [ 0.79, 1.09 ]
Total events: 141 (Favours SLI), 152 (Standard inflations)
Heterogeneity: Chi2 = 3.77, df = 4 (P = 0.44); I2 =0.0%
Test for overall effect: Z = 0.95 (P = 0.34)
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Analysis 1.5. Comparison 1 Use of initial sustained inflation vs standard inflations in newborns receiving
resuscitation with no chest compressions, Outcome 5 Surfactant administration.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with no chest compressions
Outcome: 5 Surfactant administration
Study or subgroup Sustained inflations Standard inflations Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Surfactant given in the delivery room
El-Chimi 2017 0/57 0/55 Not estimable
Lindner 2005 9/31 5/30 2.5 % 1.74 [ 0.66, 4.60 ]
Ngan 2017 15/76 13/86 5.9 % 1.31 [ 0.66, 2.57 ]
Subtotal (95% CI) 164 171 8.4 % 1.43 [ 0.82, 2.49 ]
Total events: 24 (Sustained inflations), 18 (Standard inflations)
Heterogeneity: Chi2 = 0.23, df = 1 (P = 0.63); I2 =0.0%
Test for overall effect: Z = 1.28 (P = 0.20)
2 Surfactant given at any time
El-Chimi 2017 0/57 0/55 Not estimable
Jiravisitkul 2017 12/43 14/38 7.2 % 0.76 [ 0.40, 1.43 ]
Lindner 2005 18/31 17/30 8.4 % 1.02 [ 0.66, 1.58 ]
Lista 2015 109/148 110/143 54.1 % 0.96 [ 0.84, 1.09 ]
Mercadante 2016 4/93 1/92 0.5 % 3.96 [ 0.45, 34.74 ]
Ngan 2017 36/76 41/86 18.6 % 0.99 [ 0.72, 1.37 ]
Schwaberger 2015 6/20 6/20 2.9 % 1.00 [ 0.39, 2.58 ]
Subtotal (95% CI) 468 464 91.6 % 0.97 [ 0.86, 1.10 ]
Total events: 185 (Sustained inflations), 189 (Standard inflations)
Heterogeneity: Chi2 = 2.33, df = 5 (P = 0.80); I2 =0.0%
Test for overall effect: Z = 0.44 (P = 0.66)
Total (95% CI) 632 635 100.0 % 1.01 [ 0.89, 1.15 ]
Total events: 209 (Sustained inflations), 207 (Standard inflations)
Heterogeneity: Chi2 = 4.74, df = 7 (P = 0.69); I2 =0.0%
Test for overall effect: Z = 0.17 (P = 0.86)
Test for subgroup differences: Chi2 = 1.80, df = 1 (P = 0.18), I2 =44%
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Analysis 1.6. Comparison 1 Use of initial sustained inflation vs standard inflations in newborns receiving
resuscitation with no chest compressions, Outcome 6 Need for mechanical ventilation.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with no chest compressions
Outcome: 6 Need for mechanical ventilation
Study or subgroup SLI Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
El-Chimi 2017 0/57 0/55 Not estimable
Jiravisitkul 2017 17/43 17/38 15.3 % 0.88 [ 0.53, 1.47 ]
Lista 2015 88/148 98/143 84.7 % 0.87 [ 0.73, 1.03 ]
Total (95% CI) 248 236 100.0 % 0.87 [ 0.74, 1.03 ]
Total events: 105 (SLI), 115 (Control)
Heterogeneity: Chi2 = 0.00, df = 1 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 1.64 (P = 0.10)
Test for subgroup differences: Not applicable
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Analysis 1.7. Comparison 1 Use of initial sustained inflation vs standard inflations in newborns receiving
resuscitation with no chest compressions, Outcome 7 Duration of NCPAP.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with no chest compressions
Outcome: 7 Duration of NCPAP
Study or subgroup Sustained inflations Standard inflations
Mean
Difference Weight
Mean
Difference
N Mean(SD)[days] N Mean(SD)[days] IV,Fixed,95% CI IV,Fixed,95% CI
El-Chimi 2017 57 6.89 (10.39) 55 9.71 (10.79) 1.4 % -2.82 [ -6.75, 1.11 ]
Lindner 2005 28 14.5 (9.5) 30 19.9 (17.3) 0.4 % -5.40 [ -12.52, 1.72 ]
Mercadante 2016 93 2.96 (1.7) 92 2.63 (1.5) 98.2 % 0.33 [ -0.13, 0.79 ]
Total (95% CI) 178 177 100.0 % 0.26 [ -0.19, 0.72 ]
Heterogeneity: Chi2 = 4.88, df = 2 (P = 0.09); I2 =59%
Test for overall effect: Z = 1.13 (P = 0.26)
Test for subgroup differences: Not applicable
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Analysis 1.8. Comparison 1 Use of initial sustained inflation vs standard inflations in newborns receiving
resuscitation with no chest compressions, Outcome 8 Duration of mechanical ventilation.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with no chest compressions
Outcome: 8 Duration of mechanical ventilation
Study or subgroup SLI control
Mean
Difference Weight
Mean
Difference
N Mean(SD)[days] N Mean(SD)[days] IV,Fixed,95% CI IV,Fixed,95% CI
Mercadante 2016 93 3.5 (2.8) 92 0.08 (0) Not estimable
Lindner 2005 28 15.3 (20.5) 30 14.6 (17.9) 0.9 % 0.70 [ -9.23, 10.63 ]
Jiravisitkul 2017 42 1.5 (3.35) 37 4.13 (5.65) 20.2 % -2.63 [ -4.71, -0.55 ]
Schwaberger 2015 20 0.75 (2.02) 20 1.9 (3.42) 29.0 % -1.15 [ -2.89, 0.59 ]
Ngan 2017 76 7.54 (3.8) 86 16.58 (4.8) 49.9 % -9.04 [ -10.37, -7.71 ]
Total (95% CI) 259 265 100.0 % -5.37 [ -6.31, -4.43 ]
Heterogeneity: Chi2 = 60.07, df = 3 (P<0.00001); I2 =95%
Test for overall effect: Z = 11.23 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.9. Comparison 1 Use of initial sustained inflation vs standard inflations in newborns receiving
resuscitation with no chest compressions, Outcome 9 Duration of respiratory support (NCPAP + MV).
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with no chest compressions
Outcome: 9 Duration of respiratory support (NCPAP + MV)
Study or subgroup Sustained inflations Standard inflations
Mean
Difference Weight
Mean
Difference
N Mean(SD)[days] N Mean(SD)[days] IV,Fixed,95% CI IV,Fixed,95% CI
Lindner 2005 28 29.8 (25.7) 30 34.6 (26.9) 0.1 % -4.80 [ -18.34, 8.74 ]
Mercadante 2016 93 3.3 (1.4) 92 2.6 (1.8) 99.9 % 0.70 [ 0.23, 1.17 ]
Total (95% CI) 121 122 100.0 % 0.69 [ 0.23, 1.16 ]
Heterogeneity: Chi2 = 0.63, df = 1 (P = 0.43); I2 =0.0%
Test for overall effect: Z = 2.92 (P = 0.0034)
Test for subgroup differences: Not applicable
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Analysis 1.10. Comparison 1 Use of initial sustained inflation vs standard inflations in newborns receiving
resuscitation with no chest compressions, Outcome 10 Duration of supplemental oxygen requirement.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with no chest compressions
Outcome: 10 Duration of supplemental oxygen requirement
Study or subgroup SLI Control
Mean
Difference
Mean
Difference
N Mean(SD)[days] N Mean(SD)[days] IV,Fixed,95% CI IV,Fixed,95% CI
Jiravisitkul 2017 43 26.38 (25.07) 38 36.11 (42.06) -9.73 [ -25.06, 5.60 ]
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Analysis 1.11. Comparison 1 Use of initial sustained inflation vs standard inflations in newborns receiving
resuscitation with no chest compressions, Outcome 11 Chronic lung disease.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with no chest compressions
Outcome: 11 Chronic lung disease
Study or subgroup Sustained inflations Standard inflations Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 BPD any grade
Lindner 2005 4/28 6/30 4.1 % 0.71 [ 0.22, 2.27 ]
Ngan 2017 41/76 50/86 33.5 % 0.93 [ 0.71, 1.22 ]
Subtotal (95% CI) 104 116 37.7 % 0.90 [ 0.69, 1.19 ]
Total events: 45 (Sustained inflations), 56 (Standard inflations)
Heterogeneity: Chi2 = 0.19, df = 1 (P = 0.66); I2 =0.0%
Test for overall effect: Z = 0.72 (P = 0.47)
2 Moderate to severe BPD
El-Chimi 2017 6/57 1/52 0.7 % 5.47 [ 0.68, 43.96 ]
Jiravisitkul 2017 4/43 8/38 6.1 % 0.44 [ 0.14, 1.35 ]
Lista 2015 57/148 50/143 36.3 % 1.10 [ 0.81, 1.49 ]
Ngan 2017 16/76 27/86 18.1 % 0.67 [ 0.39, 1.15 ]
Schwaberger 2015 0/20 1/20 1.1 % 0.33 [ 0.01, 7.72 ]
Subtotal (95% CI) 344 339 62.3 % 0.95 [ 0.74, 1.22 ]
Total events: 83 (Sustained inflations), 87 (Standard inflations)
Heterogeneity: Chi2 = 7.48, df = 4 (P = 0.11); I2 =47%
Test for overall effect: Z = 0.39 (P = 0.70)
Total (95% CI) 448 455 100.0 % 0.93 [ 0.77, 1.13 ]
Total events: 128 (Sustained inflations), 143 (Standard inflations)
Heterogeneity: Chi2 = 7.72, df = 6 (P = 0.26); I2 =22%
Test for overall effect: Z = 0.72 (P = 0.47)
Test for subgroup differences: Chi2 = 0.07, df = 1 (P = 0.79), I2 =0.0%
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Analysis 1.12. Comparison 1 Use of initial sustained inflation vs standard inflations in newborns receiving
resuscitation with no chest compressions, Outcome 12 Pneumothorax.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with no chest compressions
Outcome: 12 Pneumothorax
Study or subgroup Sustained inflations Standard inflations Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 During first 48 hours
Jiravisitkul 2017 1/43 1/38 6.5 % 0.88 [ 0.06, 13.65 ]
Subtotal (95% CI) 43 38 6.5 % 0.88 [ 0.06, 13.65 ]
Total events: 1 (Sustained inflations), 1 (Standard inflations)
Heterogeneity: not applicable
Test for overall effect: Z = 0.09 (P = 0.93)
2 At any time
El-Chimi 2017 4/57 6/55 37.7 % 0.64 [ 0.19, 2.16 ]
Lindner 2005 3/31 4/30 25.1 % 0.73 [ 0.18, 2.97 ]
Lista 2015 9/148 2/143 12.6 % 4.35 [ 0.96, 19.78 ]
Mercadante 2016 3/93 0/92 3.1 % 6.93 [ 0.36, 132.22 ]
Ngan 2017 2/76 1/86 5.8 % 2.26 [ 0.21, 24.47 ]
Schwaberger 2015 0/20 1/20 9.3 % 0.33 [ 0.01, 7.72 ]
Subtotal (95% CI) 425 426 93.5 % 1.44 [ 0.76, 2.72 ]
Total events: 21 (Sustained inflations), 14 (Standard inflations)
Heterogeneity: Chi2 = 6.72, df = 5 (P = 0.24); I2 =26%
Test for overall effect: Z = 1.12 (P = 0.26)
Total (95% CI) 468 464 100.0 % 1.40 [ 0.76, 2.61 ]
Total events: 22 (Sustained inflations), 15 (Standard inflations)
Heterogeneity: Chi2 = 6.77, df = 6 (P = 0.34); I2 =11%
Test for overall effect: Z = 1.07 (P = 0.28)
Test for subgroup differences: Chi2 = 0.12, df = 1 (P = 0.73), I2 =0.0%
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Analysis 1.13. Comparison 1 Use of initial sustained inflation vs standard inflations in newborns receiving
resuscitation with no chest compressions, Outcome 13 Cranial ultrasound abnormalities.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with no chest compressions
Outcome: 13 Cranial ultrasound abnormalities
Study or subgroup Sustained inflations Standard inflations Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Intraventricular haemorrhage grade 3-4
Jiravisitkul 2017 0/43 2/38 7.1 % 0.18 [ 0.01, 3.58 ]
Lindner 2005 3/31 2/30 5.5 % 1.45 [ 0.26, 8.09 ]
Lista 2015 12/148 8/143 21.9 % 1.45 [ 0.61, 3.44 ]
Ngan 2017 17/76 26/86 65.6 % 0.74 [ 0.44, 1.25 ]
Schwaberger 2015 0/20 0/20 Not estimable
Subtotal (95% CI) 318 317 100.0 % 0.89 [ 0.58, 1.37 ]
Total events: 32 (Sustained inflations), 38 (Standard inflations)
Heterogeneity: Chi2 = 3.11, df = 3 (P = 0.37); I2 =4%
Test for overall effect: Z = 0.52 (P = 0.60)
2 IVH any grade
El-Chimi 2017 10/57 12/55 92.4 % 0.80 [ 0.38, 1.71 ]
Schwaberger 2015 1/20 1/20 7.6 % 1.00 [ 0.07, 14.90 ]
Subtotal (95% CI) 77 75 100.0 % 0.82 [ 0.40, 1.69 ]
Total events: 11 (Sustained inflations), 13 (Standard inflations)
Heterogeneity: Chi2 = 0.02, df = 1 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 0.54 (P = 0.59)
3 Cystic periventricular leukomalacia
Jiravisitkul 2017 1/43 1/38 8.4 % 0.88 [ 0.06, 13.65 ]
Lindner 2005 2/31 4/30 32.3 % 0.48 [ 0.10, 2.45 ]
Lista 2015 1/148 5/143 40.4 % 0.19 [ 0.02, 1.63 ]
Ngan 2017 1/76 2/86 14.9 % 0.57 [ 0.05, 6.12 ]
Schwaberger 2015 2/20 0/20 4.0 % 5.00 [ 0.26, 98.00 ]
Subtotal (95% CI) 318 317 100.0 % 0.59 [ 0.24, 1.44 ]
Total events: 7 (Sustained inflations), 12 (Standard inflations)
Heterogeneity: Chi2 = 3.17, df = 4 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 1.16 (P = 0.25)
Test for subgroup differences: Chi2 = 0.68, df = 2 (P = 0.71), I2 =0.0%
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Analysis 1.14. Comparison 1 Use of initial sustained inflation vs standard inflations in newborns receiving
resuscitation with no chest compressions, Outcome 14 Retinopathy of prematurity (ROP) stage ≥ 3.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with no chest compressions
Outcome: 14 Retinopathy of prematurity (ROP) stage≥ 3
Study or subgroup Sustained inflations Standard inflations Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Jiravisitkul 2017 0/43 4/38 12.3 % 0.10 [ 0.01, 1.77 ]
Lindner 2005 5/28 5/30 12.5 % 1.07 [ 0.35, 3.31 ]
Lista 2015 14/148 12/143 31.5 % 1.13 [ 0.54, 2.35 ]
Ngan 2017 7/76 18/86 43.6 % 0.44 [ 0.19, 1.00 ]
Schwaberger 2015 0/20 0/20 Not estimable
Total (95% CI) 315 317 100.0 % 0.69 [ 0.44, 1.10 ]
Total events: 26 (Sustained inflations), 39 (Standard inflations)
Heterogeneity: Chi2 = 5.19, df = 3 (P = 0.16); I2 =42%
Test for overall effect: Z = 1.54 (P = 0.12)
Test for subgroup differences: Not applicable
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Analysis 1.15. Comparison 1 Use of initial sustained inflation vs standard inflations in newborns receiving
resuscitation with no chest compressions, Outcome 15 Patent ductus arteriosus (PDA).
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with no chest compressions
Outcome: 15 Patent ductus arteriosus (PDA)
Study or subgroup Sustained inflations Standard inflations Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 PDA - pharmacological treatment
El-Chimi 2017 8/57 11/53 8.9 % 0.68 [ 0.29, 1.55 ]
Jiravisitkul 2017 18/43 14/38 11.6 % 1.14 [ 0.66, 1.96 ]
Lindner 2005 13/31 7/30 5.6 % 1.80 [ 0.83, 3.88 ]
Lista 2015 88/148 70/143 55.7 % 1.21 [ 0.98, 1.50 ]
Ngan 2017 13/76 21/86 15.4 % 0.70 [ 0.38, 1.30 ]
Schwaberger 2015 0/20 3/20 2.7 % 0.14 [ 0.01, 2.60 ]
Subtotal (95% CI) 375 370 100.0 % 1.08 [ 0.90, 1.30 ]
Total events: 140 (Sustained inflations), 126 (Standard inflations)
Heterogeneity: Chi2 = 7.83, df = 5 (P = 0.17); I2 =36%
Test for overall effect: Z = 0.84 (P = 0.40)
2 PDA - surgical closure
Jiravisitkul 2017 1/43 0/38 6.1 % 2.66 [ 0.11, 63.40 ]
Lista 2015 5/148 8/143 93.9 % 0.60 [ 0.20, 1.80 ]
Schwaberger 2015 0/20 0/20 Not estimable
Subtotal (95% CI) 211 201 100.0 % 0.73 [ 0.27, 1.99 ]
Total events: 6 (Sustained inflations), 8 (Standard inflations)
Heterogeneity: Chi2 = 0.75, df = 1 (P = 0.39); I2 =0.0%
Test for overall effect: Z = 0.62 (P = 0.54)
Test for subgroup differences: Chi2 = 0.57, df = 1 (P = 0.45), I2 =0.0%
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Analysis 2.1. Comparison 2 Use of initial sustained inflation vs standard inflations in newborns receiving
resuscitation with chest compressions, Outcome 1 Death.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 2 Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with chest compressions
Outcome: 1 Death
Study or subgroup SLI control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Death before discharge
Schmo¨lzer 2015 2/5 1/4 1.60 [ 0.21, 11.92 ]
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Analysis 2.2. Comparison 2 Use of initial sustained inflation vs standard inflations in newborns receiving
resuscitation with chest compressions, Outcome 2 Endotracheal intubation.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 2 Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with chest compressions
Outcome: 2 Endotracheal intubation
Study or subgroup Favours SLI Standard inflations Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Endotracheal intubation in the delivery room
Schmo¨lzer 2015 5/5 4/4 1.00 [ 0.68, 1.46 ]
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Analysis 2.3. Comparison 2 Use of initial sustained inflation vs standard inflations in newborns receiving
resuscitation with chest compressions, Outcome 3 Surfactant administration.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 2 Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with chest compressions
Outcome: 3 Surfactant administration
Study or subgroup Sustained inflations Standard inflations Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Surfactant given in the delivery room
Schmo¨lzer 2015 4/5 2/4 1.60 [ 0.55, 4.68 ]
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Analysis 2.4. Comparison 2 Use of initial sustained inflation vs standard inflations in newborns receiving
resuscitation with chest compressions, Outcome 4 Chronic lung disease.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 2 Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with chest compressions
Outcome: 4 Chronic lung disease
Study or subgroup Sustained inflations Standard inflations Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Moderate to severe BPD
Schmo¨lzer 2015 2/3 3/4 0.89 [ 0.33, 2.37 ]
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Analysis 2.5. Comparison 2 Use of initial sustained inflation vs standard inflations in newborns receiving
resuscitation with chest compressions, Outcome 5 Pneumothorax.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 2 Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with chest compressions
Outcome: 5 Pneumothorax
Study or subgroup Sustained inflations Standard inflations Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 At any time
Schmo¨lzer 2015 0/5 0/4 Not estimable
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Analysis 2.6. Comparison 2 Use of initial sustained inflation vs standard inflations in newborns receiving
resuscitation with chest compressions, Outcome 6 Cranial ultrasound abnormalities.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 2 Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with chest compressions
Outcome: 6 Cranial ultrasound abnormalities
Study or subgroup Sustained inflations Standard inflations Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Intraventricular haemorrhage grade 3 to 4
Schmo¨lzer 2015 1/5 2/4 0.40 [ 0.05, 2.98 ]
2 IVH any grade
Schmo¨lzer 2015 1/5 4/4 0.28 [ 0.07, 1.15 ]
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Analysis 2.7. Comparison 2 Use of initial sustained inflation vs standard inflations in newborns receiving
resuscitation with chest compressions, Outcome 7 Retinopathy of prematurity (ROP) stage ≥ 3.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 2 Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with chest compressions
Outcome: 7 Retinopathy of prematurity (ROP) stage≥ 3
Study or subgroup Sustained inflations Standard inflations Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Schmo¨lzer 2015 1/5 3/4 0.27 [ 0.04, 1.68 ]
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Analysis 2.8. Comparison 2 Use of initial sustained inflation vs standard inflations in newborns receiving
resuscitation with chest compressions, Outcome 8 Patent ductus arteriosus (PDA).
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 2 Use of initial sustained inflation vs standard inflations in newborns receiving resuscitation with chest compressions
Outcome: 8 Patent ductus arteriosus (PDA)
Study or subgroup Sustained inflations Standard inflations Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 PDA - pharmacological treatment
Schmo¨lzer 2015 2/5 4/4 0.46 [ 0.17, 1.25 ]
0.01 0.1 1 10 100
Favours SLI Favours control
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A D D I T I O N A L T A B L E S
Table 1. Populations and interventions in included trials
Trial
(no.
infants)
Antenatal steroids Gestational age, weeks Birth weight, grams Device/
Interface
Interventions/Controls
SLI Control SLI Control SLI Control SLI and
control
SLI Control
El-Chimi
2017
(112)
39% 34.5% mean 31.1
(SD 1.7)
mean 31.3
(SD 1.7)
mean 1561
(SD 326)
mean 1510
(SD 319)
Mask and
T-piece in
SLI group
Mask
and self-in-
flating bag
with
an oxygen
reservoir in
control
group
PIP of 20
cmH2O
for 15 sec-
onds, fol-
lowed by
PEEP of 5
cmH2O
If needed:
a
second SLI
of 15 sec-
onds of 25
cmH2O
for 15 sec-
onds, fol-
lowed
by PEEP of
6 cmH2O;
then
a third SLI
of 15 sec-
onds of 30
cmH2O
for 15 sec-
onds, fol-
lowed by
PEEP of 7
cmH2O
If still not
satis-
factory: in-
tubated
in delivery
room
PIP maxi-
mum 40
cmH2O,
rate of 40
to
60 breaths/
min for 30
seconds
Jiravisitkul
2017 (81)
63% 74% 25 to 28
weeks:
n = 17;
29 to 32
weeks:
n = 26
25 to 28
weeks:
n = 16;
29 to 32
weeks:
n = 22
mean 1206
(SD 367)
mean 1160
(SD 411)
Mask and
T-piece
PIP of 25
cmH2O
for 15 sec-
onds
If
PIP 15 to
20
cmH2O,
PEEP
5 cmH2O
66Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 1. Populations and interventions in included trials (Continued)
HR 60 to
100 beats/
min and/
or poor
respiratory
effort: a
second SLI
(25
cmH2O,
15
seconds)
for 30 sec-
onds, fol-
lowed
by resusci-
tation ac-
cording to
AHA
guidelines
Lindner
2005 (61)
81% 80% median27.
0 (IQR 25.
0 to 28.9)
median26.
7 (IQR 25.
0 to 28.9)
median
870 (IQR
410 to
1320)
median
830 (IQR
370 to
1370)
Nasopha-
ryngeal
tube (fixed
at 4 to
5 cm) and
mechani-
cal ventila-
tor
PIP of 20
cmH2O
for 15 sec-
onds
If response
was not
sat-
isfactory: 2
further
SLIs of
15 seconds
(25 and 30
cmH2O).
Then
PEEP at 4
to 6
cmH2O
PIP 20
cmH2O,
PEEP 4 to
6 cmH2O;
inflation
time 0.
5 seconds;
inflation
rate 60 per
min.
Then,
PEEP at 4
to 6
cmH2O
Lista 2015
(301)
87% 91% mean 26.8
(SD 1.2);
25 to 26
weeks:
n = 55
27 to 28
weeks:
n = 88
mean 26.8
(SD 1.1);
25 to 26
weeks:
n = 52;
27 to 28
weeks:
n = 96
mean 894
(SD 247)
mean 893
(SD 241)
Mask and
T-piece
PIP 25
cmH2O
for 15 sec-
onds.
Then
reduced to
PEEP of 5
cmH2O
PEEP
5 cmH2O,
followed
by resusci-
tation ac-
cording to
AHA
guidelines
Mer-
cadante
2016
(185)
40% 32% mean 35.2
(SD 0.8)
mean 35.2
(SD 0.8)
mean 2345
(SD 397)
mean 2346
(SD 359)
Mask and
T-piece
PIP 25
cmH2O
for 15 sec-
onds, fol-
lowed
by PEEP of
5 cmH2O.
In case of
persistent
PEEP
5 cmH2O,
followed
by resusci-
tation ac-
cord-
ing to AAP
guidelines
67Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 1. Populations and interventions in included trials (Continued)
heart fail-
ure (HR <
100 bpm)
: SLI re-
peated
Ngan
2017
(162)
78% 70% mean 28
(SD 2.5)
mean 28
(SD 2.5)
mean 1154
(SD 426)
mean 1140
(SD 406)
Mask and
T-piece
Two PIPs
of 24
cmH2O.
Duration
of first SLI
was 20
seconds.
Duration
of second
SLI was
20 or 10
seconds,
guided
by ECO2
values.
After SLIs,
CPAP if
breathing
sponta-
neously or,
if found
to have
apnoea or
laboured
breathing,
mask
IPPV at a
rate of 40
to 60 bpm
IPPV,
rate of 40
to 60 infla-
tions/min
until spon-
taneous
breathing,
at which
timeCPAP
will be pro-
vided
Schmölzer
2015 (9)
80%a 100%a mean 24.6
(SD 1.3)a
mean 25.6
(SD 2.3)a
mean 707
(SD 208)a
mean 808
(SD 192)a
Mask and
T-piecea
PIP for 20
+ 20 sec-
ondsa dur-
ing
chest com-
pressions
3:
1 compres-
sion:ven-
tilation ra-
tio accord-
ing to re-
suscitation
guidelines
Schwaberger
2015 (40)
not
reported
not
reported
mean 32.1
(SD 1.4)
mean 32.1
(SD 1.6)
mean 1692
(SD 297)
mean 1722
(SD 604)
Mask and
T-piece
PIP 30
cmH2O
for 15 sec-
onds, to be
Resus-
citation ac-
cording to
AHA
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Table 1. Populations and interventions in included trials (Continued)
repeated
once or
twice with
HR re-
maining <
100 bpm.
Infants
with HR >
100 bpm:
PPV at 30
cmH2O
PIP
or CPAP at
PEEP level
of
5 cmH2O
depending
on respira-
tory rate
guidelines
PEEP 5
cmH2O if
respi-
ratory rate
> 30 and
signs of
respiratory
distress
PPV at 30
cmH2O
PIP if
insuffi-
cient
breathing
efforts
aInformation provided by study authors
A P P E N D I C E S
Appendix 1. Standard search method
PubMed: ((infant, newborn[MeSH] OR newborn OR neonate OR neonatal OR premature OR low birth weight OR VLBW OR
LBW or infan* or neonat*) AND (randomized controlled trial [pt] OR controlled clinical trial [pt] OR randomized [tiab] OR placebo
[tiab] OR drug therapy [sh] OR randomly [tiab] OR trial [tiab] OR groups [tiab]) NOT (animals [mh] NOT humans [mh]))
Embase: (infant, newborn or newborn or neonate or neonatal or premature or very low birth weight or low birth weight or VLBW or
LBW or Newborn or infan* or neonat*) AND (human not animal) AND (randomized controlled trial or controlled clinical trial or
randomized or placebo or clinical trials as topic or randomly or trial or clinical trial)
CINAHL: (infant, newborn OR newborn OR neonate OR neonatal OR premature OR low birth weight OR VLBW OR LBW or
Newborn or infan* or neonat*) AND (randomized controlled trial OR controlled clinical trial OR randomized OR placebo OR clinical
trials as topic OR randomly OR trial OR PT clinical trial)
Cochrane Library: (infant or newborn or neonate or neonatal or premature or preterm or very low birth weight or low birth weight or
VLBW or LBW)
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Appendix 2. Risk of bias tool
We used the standard methods of Cochrane and Cochrane Neonatal to assess themethodological quality (to meet the validity criteria) of
the trials. For each trial, we sought information regarding the method of randomisation, and the blinding and reporting of all outcomes
of all infants enrolled in the trial. We assessed each criterion as low, high, or unclear risk. Two review authors separately assessed each
study. We resolved any disagreement by discussion. We added this information to the table Characteristics of included studies. We
evaluated the following issues and entered the findings into the risk of bias table.
1. Sequence generation (checking for possible selection bias). Was the allocation sequence adequately generated?
For each included study, we categorised the method used to generate the allocation sequence as:
a. low risk (any truly random process, e.g. random number table; computer random number generator);
b. high risk (any non-random process, e.g. odd or even date of birth; hospital or clinic record number); or
c. unclear risk.
2. Allocation concealment (checking for possible selection bias). Was allocation adequately concealed?
For each included study, we categorised the method used to conceal the allocation sequence as:
a. low risk (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);
b. high risk (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth); or
c. unclear risk.
3. Blinding of participants and personnel (checking for possible performance bias). Was knowledge of the allocated intervention
adequately prevented during the study?
For each included study, we categorised the methods used to blind study participants and personnel from knowledge of which
intervention a participant received. Blinding was assessed separately for different outcomes or classes of outcomes. We categorised the
methods as:
a. low risk, high risk, or unclear risk for participants; and
b. low risk, high risk, or unclear risk for personnel.
4. Blinding of outcome assessment (checking for possible detection bias). Was knowledge of the allocated intervention adequately
prevented at the time of outcome assessment?
For each included study, we categorised the methods used to blind outcome assessment. Blinding was assessed separately for different
outcomes or classes of outcomes. We categorized the methods as:
a. low risk for outcome assessors;
b. high risk for outcome assessors; or
c. unclear risk for outcome assessors.
5. Incomplete outcome data (checking for possible attrition bias through withdrawals, dropouts, protocol deviations). Were incomplete
outcome data adequately addressed?
For each included study and for each outcome, we described the completeness of data including attrition and exclusions from the
analysis. We noted whether attrition and exclusions were reported, the numbers included in the analysis at each stage (compared with
the total randomised participants), reasons for attrition or exclusion when reported, and whether missing data were balanced across
groups or were related to outcomes. When sufficient information was reported or supplied by trial authors, we re-included missing
data in the analyses. We categorised the methods as:
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a. low risk (< 20% missing data);
b. high risk (≥ 20% missing data); or
c. unclear risk.
6. Selective reporting bias. Are reports of the study free of suggestion of selective outcome reporting?
For each included study, we described how we investigated the possibility of selective outcome reporting bias and what we found. We
assessed the methods as:
a. low risk (when it is clear that all of the study’s prespecified outcomes and all expected outcomes of interest to the review have been
reported);
b. high risk (when not all of the study’s prespecified outcomes have been reported; one or more reported primary outcomes were not
prespecified outcomes of interest and are reported incompletely and so cannot be used; study fails to include results of a key outcome
that would have been expected to have been reported); or
c. unclear risk.
7. Other sources of bias. Was the study apparently free of other problems that could put it at high risk of bias?
For each included study, we described any important concerns we had about other possible sources of bias (e.g. whether a potential
source of bias was related to the specific study design, whether the trial was stopped early owing to some data-dependent process). We
assessed whether each study was free of other problems that could put it at risk of bias as:
a. low risk;
b. high risk; or
c. unclear risk.
If needed, we explored the impact of the level of bias by undertaking sensitivity analyses.
WH A T ’ S N E W
Last assessed as up-to-date: 17 February 2017.
Date Event Description
21 July 2017 Amended Typo corrected: Schwaberger 2015 used near-infrared spectroscopy (NIRS) not a numerical rating scale
(NRS)
H I S T O R Y
Protocol first published: Issue 4, 2004
Review first published: Issue 7, 2015
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Date Event Description
13 June 2017 New citation required but conclusions have not changed We included six new studies but made no changes to the
main conclusions
13 June 2017 New search has been performed We updated searches in 2017 and found six new eligible
studies for inclusion
6 July 2015 Amended We updated review author affiliation
10 July 2008 Amended We converted the review to new review format
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We added clinically relevant outcomes (surfactant administration, need for mechanical ventilation, retinopathy of prematurity, and
PDA).
We planned subgroup analyses according to gestational age (< 37 weeks, ≥ 37 weeks), ventilation device used (self-inflating bag, flow-
inflating bag, T-piece, mechanical ventilator), patient interface used (face mask, ETT, nasopharyngeal tube), and duration of sustained
inflation (> 1 second to 5 seconds, > 5 seconds). We were unable to conduct any subgroup analyses as few trials met the inclusion
criteria.
For this update, we made the post hoc decision to add a comparison based on use of chest compression during resuscitation. Moreover,
we specified Unit of analysis issues and Sensitivity analysis.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Ductus Arteriosus, Patent [epidemiology]; Hospital Mortality; Intubation, Intratracheal [methods; mortality]; Positive-Pressure Respi-
ration [∗methods; mortality]; Pulmonary Surfactants [administration & dosage]; Randomized Controlled Trials as Topic; Resuscitation
[∗methods]; Time Factors
MeSH check words
Humans; Infant, Newborn
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